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ABSTRACT 
The WNT signaling pathway plays numerous roles in development and maintenance of adult 
homeostasis. In concordance with its numerous roles, dysfunction of WNT signaling leads to a 
variety of human diseases ranging from developmental disorders to cancer. WNT signaling is 
composed of a family of 19 WNT soluble secreted glycoproteins, which are evolutionarily 
conserved across all phyla of the animal kingdom. WNT ligands interact most commonly with a 
family of receptors known as frizzled (FZ) receptors, composed of 10 independent genes. 
Specific interactions between WNT proteins and FZ receptors are not well characterized and are 
known to be promiscuous, Traditionally canonical WNT signaling is described as a binary system 
in which WNT signaling is either off or on. In the ‘off’ state, in the absence of a WNT ligand, 
cytoplasmic β-catenin is continuously degraded by the action of the APC/Axin/GSK-3β 
destruction complex. In the ‘on’ state, when WNT binds to its Frizzled (Fz) receptor and LRP 
coreceptor, this protein destruction complex is disrupted, allowing β-catenin to translocate into the 
nucleus where it interacts with the DNA-bound T cell factor/lymphoid factor (TCF/LEF) family of 
proteins to regulate target gene expression. However in a variety of systems in development and 
disease canonical WNT signaling acts in a gradient fashion, suggesting more complex regulation 
of β-catenin transcriptional activity. As such, the traditional ‘binary’ view of WNT signaling does 
not clearly explain how this graded signal is transmitted intracellularly to control concentration-
dependent changes in gene expression and cell identity. I have developed an in vitro human 
pluripotent stem cell (hPSC)-based model that recapitulates the same in vivo developmental 
effects of the WNT signaling gradient on the anterior-posterior (A/P) patterning of the neural tube 
observed during early development. Using RNA-seq and ChIP-seq I have characterized β-catenin 
binding at different levels of WNT signaling and identified different classes of β-catenin peaks that 
bind cis-regulatory elements to influence neural cell fate. This work expands the traditional binary 
view of canonical WNT signaling and illuminates WNT/β-catenin activity in other developmental 
and diseased contexts. 
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CHAPTER 1 
  INTRODUCTION 
1.1. Stem Cells and Pluripotency 
Stem cells are defined quite simply as cells that have the capacity to indefinitely self renew and 
differentiate into more terminal cell types (Ding & Schultz, 2004). This broad definition 
encompasses two overarching categories of stem cells, pluripotent stem cells and adult stem 
cells. Adult stem cells are rare resident stem cells that reside in postnatal stem cell niches, 
maintaining populations of adult cells in organisms. While pluripotent stem cells have the capacity 
to be differentiate into almost any cell type in the body, and are typically found in embryos.  
1.1.1. Discovery of embryonic stem cells 
The first isolation of pluripotent stem cells was the embryonic stem cell (ESC), first isolated 
in mice in 1981 by Evans and Kauffman (Evans & Kaufman, 1981). This breakthrough discovery 
required careful optimization the isolation of mouse blastocysts with identification of passaging 
conditions required to maintain them. Their work paid off and yielded cell lines with a normal 
karyotype capable of being serially passaged and differentiating into all three germ layers in 
teratocarcinomas (Evans & Kaufman, 1981). Gail Martin subsequently published a method for 
isolating mouse embryonic stem cells (mESCs) from the inner cell mass (ICM) of embryos 
instead of culture of whole blastocysts that was employed by Evans and Kauffman (G. R. Martin, 
1981). Seventeen years passed between the initial isolation of mESCs and human embryonic 
stem cells (hESCs) by Jaime Thompson in 1998 using an ICM isolation technique (Thomson et 
al., 1998). 
The breakthrough discovery of stem cells enabled the study of basic science in many 
ways including developmental biology, disease modeling, as well as more applied therapeutic 
interventions such as high throughput drug screening, and cell replacement therapies. The 
isolation of murine embryonic stem cells along with the discovery of homologous recombination 
opened up the potential to use these cells to study development in a groundbreaking new way 
enabling the generation of reporter lines, genetic knockouts, and conditional genetic knockouts in 
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mice and cell culture platforms, which are powerful tools to assess the specific effects of genes 
on aspects of development (Babinet & Cohen-Tannoudji, 2001; Limaye, Hall, & Kulkarni, 2009; 
Vasquez, Marburger, Intody, & Wilson, 2001). ESCs provided the ability to create chimeras in 
edited mESCs, able to contribute to the generation of every tissue of the new animal. By 
analyzing the phenotype of knockout mice it was possible to deduce the function of a gene. This 
process, although not always perfect allowed the generation of a framework for how genes affect 
development and different phenotypes. Some genes that are critical for development, when 
knocked out, lead to an embryonic lethal phenotype, severely impairing study into their action. 
This problem can be overcome by several approaches, including conditional knockouts using a 
cre/loxp system or by introducing mutations within a gene that are less severe than an gene 
knockout (Sakamoto, Gurumurthy, & Wagner, 2014). The discovery of stem cells has made a 
tremendous impact on the field of developmental biology. 
Thompson et. al. immediately noted the enormous therapeutic potential of hESCs as a 
limitless source of differentiated cell types for cell replacement therapies for diseases such as 
Diabetes Mellitus, Parkinson’s disease, or spinal cord injury (Thomson et al., 1998). Cell 
replacement therapy could be thought of as the holy grail of stem cell research, which many 
scientists across the world still labor towards. When hESCs were first derived protocols for 
therapeutic relevant differentiations were developed such as for neurons or cardiomyocytes, but 
these needed to be dramatically improved and scaled for any attempt at human therapies. 
However since then numerous studies have documented the ability to generate almost any cell 
type with high purity including cortical neurons (Shi, Kirwan, Smith, Robinson, & Livesey, 2012), 
cholinergic neurons (Maury et al., 2015), dopaminergic neurons (Nolbrant, Heuer, Parmar, & 
Kirkeby, 2017), oligodendrocytes (Douvaras & Fossati, 2015), astrocytes (Shaltouki, Peng, Liu, 
Rao, & Zeng, 2013), cardiomyocytes (Burridge et al., 2014), hepatocytes (Roelandt, Vanhove, & 
Verfaillie, 2013), kidney glomerular podocytes (Musah, Dimitrakakis, Camacho, Church, & Ingber, 
2018), pancreatic β-cells (Rosado-Olivieri, Anderson, Kenty, & Melton, 2019), and many more. A 
problem that still plagues the field however is the generation of mature functional cell types using 
directed differentiation protocols. Many labs are working on techniques to mature these cells in 
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vitro to enable their use as cell therapeutics. However ethical challenges and the labor-intensive 
nature of hESC derivation provided major roadblocks to their use in the clinic (Hyun, 2011).   
1.1.2. Discovery of induced pluripotent stem cells 
Groundbreaking work by Shinya Yamanaka first in mouse then in human fibroblasts 
demonstrated that viral overexpression of four transcription factors Oct4, Sox2, c-Myc, and Klf4 
yielded ES like cells, dubbed induced pluripotent stem cells (iPSCs) (Takahashi et al., 2007; 
Takahashi & Yamanaka, 2006). This incredible achievement was in part possible through 
pioneering somatic cell nuclear transfer experiments by John Gurdon, which demonstrated that 
DNA is conserved throughout differentiation and the differentiated cell state is reversible through 
factors present in oocytes (De Robertis & Gurdon, 1977; Gurdon, 1962; Gurdon & Uehlinger, 
1966; Laskey & Gurdon, 1970; Wilmut, Schnieke, McWhir, Kind, & Campbell, 1997). Together 
these two scientists, Shinya Yamanaka and John Gurdon, shared the 2012 Nobel Prize in 
physiology or medicine for the discovery that mature cells can be reprogrammed to become 
pluripotent (Jaenisch, 2012). This discovery forever revolutionized the stem cell field enabling 
studies into the nature of pluripotency, the unimpeded derivation of patient specific stem cell 
lines, and paved the way for clinical implementation of stem cell therapies.  
Initial retroviral based methods used to overexpress the Yamanaka factors subjected cells 
to insertional mutagenesis, which could lead to deleterious insertions akin to initial retroviral 
attempts at gene therapy (Hacein-Bey-Abina et al., 2003; McCormack & Rabbitts, 2004). To 
improve the safety of potential therapeutic applications of this technology much effort has been 
dedicated to developing non incorporating, or footprint free, methods to generate iPSCs. There 
are a range of methods available to generate iPSCs including RNA virus (sendai) (Fusaki, Ban, 
Nishiyama, Saeki, & Hasegawa, 2009), adenovirus (Stadtfeld, Nagaya, Utikal, Weir, & 
Hochedlinger, 2008), episomal (Okita et al., 2011; Okita, Nakagawa, Hyenjong, Ichisaka, & 
Yamanaka, 2008; Su et al., 2013), mRNA (Warren et al., 2010), protein (D. Kim et al., 2009; Zhou 
et al., 2009), and small molecule based (Hou et al., 2013). Interestingly, although derivation of 
iPSCs is now widely adopted and commonplace the efficiency remains very low (~1%) 
suggesting that this process is still not completely understood and could be dependent on some 
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unknown stochastic events (Yamanaka, 2012). Future work could uncover these dependencies 
and allow high efficiency generation of high quality iPSCs. With the advent of two competing 
pluripotent stem cells important questions were raised about the differences between these two 
cell types. Initial work demonstrated both transcriptomic and epigenomic differences between 
ESCs and iPSCs (Chin et al., 2009; Deng et al., 2009; Ghosh et al., 2010; K. Kim et al., 2011; 
Lister et al., 2011; Marchetto et al., 2009; Ohi et al., 2011). However studies that compared larger 
numbers of lines found it difficult to detect differences suggesting common mechanisms of 
pluripotency between the two (Bock et al., 2011; Guenther et al., 2010; Newman & Cooper, 
2010). In summary iPSC quality is more dependent on technical aspects of derivation and that 
comprehensive characterization of lines used in research and potential therapies will be required 
before use (Yamanaka, 2012). 
1.1.3. Utility of stem cells 
Stem cells enable the study of basic science in the form developmental biology and 
disease modeling as well as enabling therapies to advance human health through the use of high 
throughput drug screening and cell therapeutics. Model organisms can be studied and modified 
extensively to provide valuable contributions to our understanding of development however the 
identical studies would not be ethically responsible to carry out in human embryos. Human 
pluripotent stem cells have dramatically advanced our understanding of human development by 
enabling rigorous examination of the events in early human development (Aach, Lunshof, Iyer, & 
Church, 2017; Warmflash, Sorre, Etoc, Siggia, & Brivanlou, 2014). Additionally iPSCs have 
facilitated the generation of patient specific lines which can be probed for differences in 
development or in terminally differentiated cells and compared to healthy lines to understand 
previously uncharacterized aspects of diseases (Y. Wang et al., 2014). This approach is 
exemplified in the study of neurodegenerative diseases (LaMarca, Powell, Akbarian, & Brennand, 
2018; Meyer et al., 2019; Ross & Akimov, 2014; Rowland, Hooper, & Kellett, 2018; Schmid et al., 
2019; Soldner et al., 2011). Patient specific lines not only allow mechanistic insight into disease 
progression but are being used as platforms to perform high content drug screens to identify 
pharmaceutical interventions for patients suffering from a variety of diseases (Ebert, Liang, & Wu, 
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2012; Mercola, Colas, & Willems, 2013; Xu & Zhong, 2013). Finally, many diseases are 
characterized by death or dysfunction in just a single cell type such as Parkinson’s disease, 
Diabetes Mellitus, spinal cord injury, or macular degeneration. These diseases offer the 
tantalizing hope of using pluripotent stem cells as a raw material to provide cells for replacement 
therapies.  
Stem cell technology is still in its infancy but it has rapidly expanded and developed into 
its own specialized field. Stem cells are used for a variety of purposes outlined above including 
developmental biology, disease modeling, and cell replacement therapies. The work described 
here used stem as a developmental biology platform to probe the fundamental mechanisms of 
WNT signaling. 
1.2. WNT Signaling 
The first WNT protein was discovered in 1976 in drosophila as a mutant allele that led to 
the loss of wing tissue. At the time it was dubbed wingless (wg) due to the observed phenotype 
and hypothesized function (Sharma & Chopra, 1976). Several years later an independent line of 
investigation by Roel Nusse and Harold Varmus, utilizing an approach to search for proto-
oncogenes near mouse mammary tumor virus (MMTV) insertion sites, led to the discovery of a 
gene called int1. For many years the function of this protein remained elusive, as it was very 
difficult to isolate (Roel Nusse & Varmus, 2012). Eventual isolation of the drosophila int1 revealed 
that that wg and int1 were orthologs due to sequence homology (Rijsewijk et al., 1987). 
Subsequently the int nomenclature proved insufficient for classifying genes, since MMTV 
integration sites do not group genes together by function, and a large family of genes related to 
int1 had been discovered (Gavin, McMahon, & McMahon, 1990). Thus the field of WNT signaling 
was born of the amalgam of the original wg and int1 genes, which proved to be orthologues (R 
Nusse et al., 1991). 
WNTs compose a large family comprising an evolutionarily conserved signaling pathway 
that constitute a secreted glycoprotein which regulate many cell processes including proliferation, 
differentiation, cell polarity, primary axis formation, cell cycle, and developmental programs of 
multiple organs (Estarás, Benner, & Jones, 2015a; Habas & Dawid, 2005; Komiya & Habas, 
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2008; Loh, van Amerongen, & Nusse, 2016). As WNT signaling controls such a diverse set of 
processes, mutations in the WNT pathway lead to many different types of diseases including 
multiple cancers (Clevers & Nusse, 2012a). 
1.2.1. WNT family of proteins 
The WNT family consists of 19 different WNT proteins. WNT proteins share a common 
structure of a stretch of 22 cysteine residues, which form disulfide bridges conferring its globular 
structure. Additionally there is a sequence of 20 hydrophobic amino acids, a hallmark of secreted 
proteins (K. Willert & Nusse, 2012). The structures for three WNT proteins have been solved in 
xenopus, drosophila, and most recently human providing insight into the function of this elusive 
group of proteins. The recent solved structure of human WNT3 bound to mouse Fzd 8 is an 
important step forward for the field since Wnt3 is a known canonical activator of WNT signaling.  
This structure revealed similarities to the previously solved xenopus structure, which was also 
conjugated to Fzd8. These structures revealed that WNT proteins are shaped reminiscent of a 
hand, consisting of two structural subdomains the N-terminal domain (NTD) C-terminal domain 
(CTD) with a variable linker domain tying the two together. Palmoteic acid modification is 
invariably located at serine residue (187), which is essential for binding the cysteine rich domain 
(CRD) of Fzd receptors (D.H. Kim et al., 2012). In WNT3 the linker domain was demonstrated to 
be essential for LRP6 coreceptor binding, a function hypothesized by earlier studies (Chu et al., 
2013; Hirai, Matoba, Mihara, Arimori, & Takagi, 2019). Somewhat controversially a 
homodimeration between WNT3-Fzd8 WNT3-Fzd8 complexes was observed in crystals that has 
been previously hypothesized to be impossible (Hirai et al., 2019; Nile, Mukund, Stanger, Wang, 
& Hannoush, 2017). Future work may elucidate distinct signaling efficiencies that may be 
associated with different ratios of WNT-Fzd complexes (Hirai et al., 2019). 
WNT secretion is a complex process, involving covalent modification with a lipid 
palmitoleic (PA) acid group by the acyl transferase porcupine (PRCN) in the ER, conferring WNTs 
renowned hydrophobicity. This property halted the purification of bioactive WNT for nearly two 
decades after its initial discovery, and still complicates isolation of additional WNTs (K. Willert et 
al., 2003). Additionally this modification complicates use of bioactive isolated WNTs, since 
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detergents are required to maintain its solubility (D. Brafman & Willert, 2017; K. Willert et al., 
2003). This modification serves to restrict WNT signalings’ range to short distances. After 
covalent addition of palmitoleic acid WNTs associate with Wls (Gpr177/Evi) a transmembrane 
protein required to shuttle WNTs to the cell surface (16678096,16678095). The function of PRCN 
and Wls to modify and secrete WNTs are essential to WNT maturation and release as indicated 
by the fact that mutations or inhibition of these proteins results in phenotypes similar to WNT3 
knockouts (Barrow et al., 2007; Biechele, Cox, & Rossant, 2011; Fu, Jiang, Mirando, Yu, & Hsu, 
2009; C. Liu et al., 1999). 
1.2.2. WNTs as morphogen gradients 
Establishment and interpretation of morphogen gradients are an essential principle of 
developing organisms (Gurdon & Bourillot, 2001). The original concept concerning interpretation 
of morphogen gradients was pioneered by Lewis Wolpert, he hypothesized that specific 
thresholds of morphogens determine cell identity, an idea that has stood the test of time (Wolpert, 
1969). There are multiple examples of Wnt morphogen gradients in development including the 
drosophila wing (Zecca, Basler, & Struhl, 1996), anteroposterior neural patterning (Kiecker & 
Niehrs, 2001; Moya, Cutts, Gaasterland, Willert, & Brafman, 2014), mouse intestinal crypts (Farin 
et al., 2016), and hematopoietic stem cells (Tiago C. Luis et al., 2011). How these gradients are 
established is an area under active fruitful investigation, whether the mechanism is through long 
or short distances is a contentious topic. Due to their known highly hydrophobic nature, Wnt 
proteins are mainly hypothesized to act through short distance mechanisms (K. Willert et al., 
2003). Strong evidence exists to support this idea in that tethered WNT in drosophila mutants 
develop normally (Alexandre, Baena-Lopez, & Vincent, 2013). Additional evidence that the 
prevalent mechanism of WNT signaling is through short range gradients comes from visualization 
of the Wnt3 gradient in intestinal cells through the use of intestinal organoids in the Clevers lab 
(Farin et al., 2016). This work demonstrates that WNT ligands are transferred to neighboring 
Lgr5+ cells and a gradient is established through cell division, which dilutes the signal. Although it 
seems short range action is the prevalent form of signaling several long range mechanisms exist 
which may have supplemental effects on establishing gradients of WNT signaling including 
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chaperone proteins (Mihara et al., 2016), actin based membrane protrusions (H. Huang & 
Kornberg, 2015; Stanganello & Scholpp, 2016) and extracellular particles (Beckett et al., 2013; Q. 
Chen, Takada, Noda, Kobayashi, & Takada, 2016; J. C. Gross, Chaudhary, Bartscherer, & 
Boutros, 2012; T. Harada et al., 2017). Future work may elucidate that alternative mechanisms of 
WNT release may play important context specific roles in development and disease. 
1.2.3. Frizzled receptors 
WNT proteins bind frizzled (FZD) receptors on the cell membrane, a large group of 
proteins consisting of 10 genes identified in organisms ranging from sponges to humans (H.-C. 
Huang & Klein, 2004). Frizzled receptors have seven transmembrane domains and are 
composed of a signal sequence, an extracellular cysteine rich domain (CRD), a hydrophobic 
transmembrane domain, and a c-terminal KTXXXW motif essential for canonical WNT signaling 
through disheveled (DVL) (Bourdelas et al., 2015; Umbhauer et al., 2000). Specific WNT-FZD 
interactions are known to be somewhat promiscuous although exact relationships still remain 
unknown, in part due to difficulties in isolating a majority of known WNT proteins (K. Willert et al., 
2003). R-spondins are secreted proteins that are able to enhance levels of WNT signaling by 
modulating availability of FZD receptors but unable to activate WNT signaling alone (de Lau, 
Snel, & Clevers, 2012). Future work characterizing exact relationships between specific WNTs 
and FZD receptors could further help elucidate functions and mechanisms of WNT signaling. 
1.2.4. Canonical WNT signaling 
WNT signaling is classically divided into two categories, canonical and non-canonical. Non-
canonical WNT signaling is typically not as well understood as canonical signaling; its activity is 
characterized by non β-catenin activity and is composed of the Ca2+ and planar cell polarity 
(PCP) pathways. Canonical WNT signaling focuses on the role of β-catenin – a structural protein 
that forms a major component of adherens junctions and is also a critical transcriptional 
coactivator required for activation of WNT target genes. The astounding complexity described 
above with respect to the diversity of WNT ligands, receptors, coreceptors, and modulators could 
account for much of the diversity of action of WNT signaling. However at least canonical WNT 
signaling converges on β-catenin to affect transcriptional outputs and influence cell fate 
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decisions. It has been suggested that certain WNT proteins act canonically while others act non-
canonically. It might be better to abandon this idea as even so called non-canonical WNTs such 
as wnt5a act canonically in different contexts (L. Gross, 2006; He et al., 1997; Mikels & Nusse, 
2006; K. Willert & Nusse, 2012). It has been suggested that a more comprehensive view of WNT 
signaling is required obviating the distinction between the two categories of signaling and 
embracing a unified view of WNT signaling as ‘cell fate’ and ‘cell polarity’ divisions (Loh, Van 
Amerongen, & Nusse, 2016). The focus of this work is on the activity and effects of β -catenin, 
non-canonical WNT signaling effects will not be further discussed.  
The molecular events of canonical WNT signaling focus on the fate of β -catenin. In the 
absence of the presence of a WNT ligand, B-catenin is continually signaled for destruction by a 
group of proteins aptly named the destruction complex. The destruction complex is composed of 
several proteins including Axin, adenomatous polyposis coli (APC), the serine/threonine kinases 
GSK3, casein kinase 1 (CK1), protein phosphatase 2A (PP2A), and the beta-transducin repeat 
containing E3 ubiquitin-protein ligase (BtrCP) (J. L. Stamos & Weis, 2013). Axin is a scaffold 
protein that contains binding sites for CK1, GSK3 and β-catenin, serving to bring the 
serine/threonine kinases CK1 and GSK3 in closer proximity to β-catenin (Yamamoto et al., 1999).  
Axin aids in the sequential phosphorylation of β -catenin by CK1 then GSK3 on multiple residues. 
Phosphorylated β-catenin is then ubiquitinated by BtrCP where it is signaled for degradation by 
the proteasome. APC is a critical component of the destruction complex, mutations in this protein 
rendering it nonfunctional lead to aberrant β-catenin accumulation and the subsequently leads to 
initiation of colorectal cancer, though the exact molecular mechanism remains incompletely 
understood (Roel Nusse & Clevers, 2017).   
In response to WNT ligand binding the destruction complex is sequestered rendering it 
unable to phosphorylate β-catenin for degradation, this occurs through the following steps. In 
canonical WNT signaling, the protein DVL aids in the polymerization of FZD and LRP in response 
to binding of a WNT ligand and aids in the recruitment of Axin to the membrane (Bilic et al., 2007; 
Gao & Chen, 2010; Zeng et al., 2008).  Since Axin is the main structural component of the 
desctruction complex, this effectively renders it ineffective at the cell membrane. Following 
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recruitment of Axin to the membrane β-catenin is hypophosphorlyated enabling its escape from 
degradation, it then accumulates in the cell cytoplasm, and translocates to the nucleus to affect 
transcription (Bilic et al., 2007; Gao & Chen, 2010; Zeng et al., 2008).  
1.2.5. TCF/LEF transcription factors 
β-catenin interaction with TCF/LEF transcription factors was initially identified from yeast 
two-hybrid screens (Behrens et al., 1996). TCF1 (HUGO gene name TCF7) and LEF1 
transcription factors were discovered through efforts to identify transcriptional regulators of cell 
fate in human T lymphocytes (Travis, Amsterdam, Belanger, & Grosschedl, 1991; M van de 
Wetering, Oosterwegel, Dooijes, & Clevers, 1991). The final two TCF transcription factors in 
human, TCF3 (HUGO gene name TCF7l1) and TCF4 (HUGO gene name TCF7l2) were identified 
using low stringency hybridization screens with TCF7 cDNA (Vladimir Korinek et al., 1998). 
Although these factors were initially characterized as part of the immunology field, subsequent 
knockout studies have demonstrated their global roles in development and disease (Archbold, 
Yang, Chen, & Cadigan, 2012; Cadigan & Waterman, 2012a). Almost all invertebrates have at 
least one copy of a TCF/LEF transcription factor, while humans have four distinct TCF/LEF TFs, 
and zebrafish have five (Archbold et al., 2012). Additional complexity in WNT signaling is 
conferred by the additional TCF/LEF transcription factors (TFs) allowing different reactions in 
response to WNT signaling depending on the availability of different TCF/LEF TFs. The structure 
of TCF/LEF factors is well characterized, with an n-terminal β-catenin binding domain, HMG 
domain, basic tail, and c-clamp regions. Mutations in n-terminus result in dominant negative 
phenotypes similar to wg knockout mutants, additional evidence which demonstrates their 
interaction with β-catenin (Marc van de Wetering et al., 1997). Together the HMG domain and 
basic tail confer the ability to bind the well-characterized 5’-SCTTTGATS-3’ consensus motif 
(Atcha et al., 2007; Hallikas & Taipale, 2006; van Beest et al., 2000; Marc van de Wetering et al., 
1997). The HMG domain recognizes to and binds this consensus motif in the minor groove of the 
DNA and elicits a 90-127 degree bend in the DNA (Giese, Amsterdam, & Grosschedl, 1991; Love 
et al., 1995). The basic tail, a short sequence of amino acids serves as a nuclear localization 
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signal and enhances DNA binding (Giese et al., 1991; Prieve, Guttridge, Munguia, & Waterman, 
1998).   
The standard model of WNT mediates transcription suggests that in the absence of β-
catenin binding TCF/LEF transcription factors act as inhibitors while binding of β-catenin induces 
transcription of WREs, this model is supported by studies in invertebrates such as 
drosophila/worms with a single TCF/LEF transcription factor (PAN – drosophila, POP1 nematode) 
(Brunner, Peter, Schweizer, & Basler, 1997; Cavallo et al., 1998; J. Liu, Phillips, Amaya, Kimble, 
& Xu, 2008; Marc van de Wetering et al., 1997). Additional specialized TCF/LEFs present in 
vertebrates which allow multiple interpretations of WNT signal, generating additional complexity. 
Generally TCF1 and LEF1 are linked to gene activation (F. Liu, van den Broek, Destrée, & 
Hoppler, 2005; T Reya et al., 2000) while TCF3 and TCF4 are linked to gene repression (C. H. 
Kim et al., 2000; Merrill et al., 2004). Although all four have been demonstrated to have activating 
potential, LEF1 and TCF3 seem to more reliably act as activator and repressor respectively, while 
TCF1 and TCF4 seem to alternate their function based on cell and tissue specific contexts 
(Galceran, Fariñas, Depew, Clevers, & Grosschedl, 1999; V Korinek et al., 1998; Nguyen et al., 
2009; Roose et al., 1999; Tang et al., 2008). Interestingly a mechanism has been observed 
where TCF3 is phosphorylated and disassociates from DNA, which allows TCF1 to bind and 
activate gene expression (Hikasa et al., 2010; Hikasa & Sokol, 2011). Multiple TCF/LEFs have 
evolved specialized, complex, and context specific mechanisms to control the effects of canonical 
WNT signaling.  
In the absence of β-catenin binding, TCFs have a repressive effect on WREs as discussed 
above. This effect is mediated by Groucho/TLE binds which acts as a repressive cofactor by 
binding TCF/LEF TFs to repress WNT target gene expression (Brantjes, Roose, van De 
Wetering, & Clevers, 2001; Cinnamon & Paroush, 2008; Turki-Judeh & Courey, 2012). TLEs form 
homotetramers, which both associate with nucelosomes and recruitment of HDACs to exert their 
repressive effects (Chodaparambil et al., 2014). HDAC recruitment by TLEs removes acetylation 
resulting in chromatin compaction and transcriptional repression (Ramakrishnan, Sinha, Fan, & 
Cadigan, 2018). β-catenin is hypothesized to out compete and displace TLE to recruit chromatin 
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activators and activate gene expression (Chodaparambil et al., 2014). Indeed, there appears to 
be no competition between B-catenin and TLE, as ChIP experiments shows that B-catenin and 
TLE1 are mutually exclusive in their binding patterns, suggesting there must be some sort of 
mechanism that facilitates exchange of the two (Sierra, Yoshida, Joazeiro, & Jones, 2006). 
Future work elucidating this mechanism will provide great insight into the regulation of WNT 
target genes. 
TCF/LEFs are the dominant nuclear receptors for β-catenin, indeed some studies suggest 
that β -catenin binds exclusively to these factors (Schuijers, Mokry, Hatzis, Cuppen, & Clevers, 
2014). Although evidence from several other groups indicates β-catenin may bind through 
alternate transcription factors including FOXO, SOX, PROP1, PITX2, HIF1a, and MYOD. Recent 
work provides strong evidence of TCF/LEF independent binding through what is termed a 
GHOST response (Doumpas et al., 2019). In this study all four TCF/LEF transcription factors 
were removed using CRISPR-cas9, then β-catenin ChIP-seq was performed. Results indicate β-
catenin binding and activation of some subset of genes in the absence of these classically viewed 
fundamental transcription factors. The authors suggest different classes of β-catenin peaks, those 
entirely independent of TCF/LEF binding and those that use TCF/LEF as cofactors with other 
transcription factors. These studies demonstrate that the role of β-catenin as a transcriptional 
scaffold and activator continues to evolve. 
1.2.6. β-catenin Structure and Function 
β-catenin is the focus of canonical WNT signaling and of this project as a whole. It was 
originally identified as a component of adherens junctions, one of three proteins given the latin 
name for chain, catein (Ozawa, Baribault, & Kemler, 1989). The signaling function of β-catenin 
(armadillo) was discovered independently in a screen of mutations in drosophila searching for 
segment polarity genes (Nüsslein-Volhard, Wieschaus, & Kluding, 1984). Later analysis indicated 
that β-catenin (armadillo) protein accumulated in identical patterns to wg, indicating its role in 
linking the signaling pathway to segment polarity. Now it is well known that β-catenin serves dual 
roles, one as a major component of adherens junctions and second as the main transcriptional 
activator of Wnt target genes (Mosimann, Hausmann, & Basler, 2009b; Orsulic & Peifer, 1996; 
	 	
13 
 
Tomas Valenta, Hausmann, & Basler, 2012). The structure of β-catenin is what allows it to serve 
these two disparate roles in cells. The central region of β-catenin is made of 12 armadillo repeats 
that are flanked by an n terminal domain (NTD) and C- terminal domain (CTD) (Tomas Valenta et 
al., 2012). The central armadillo region forms a long positively charged groove that facilitates 
binding to E-caderin at cell junctions, AXIN/APC in the cytoplasm, and TCF/LEF in the nucleus 
(Huber, Nelson, & Weis, 1997). Multiple studies have begun to parse apart the different functions 
of β-catenin in a cellular context. Lyashenko et. al. have demonstrated that β-catenin was 
dispensable for maintenance of mESC pluripotency (Lyashenko et al., 2011). Reintroduction of a 
signaling deficient β-catenin rescued the ability to differentiate into ectoderm and endoderm but 
not mesoderm, indicating the differential requirements of β-catenin function in different germ 
layers. In a similar strain Valenta et al created signaling deficient β-catenin by mutating the N- 
and C- termini to examine the differential role of β-catenin in the developing dorsal neural tube, 
where they demonstrated the essential activity of transcriptional β-catenin to maintain progenitor 
identity and neuronal differentiation in the dorsal spinal cord (Tomas Valenta et al., 2011). β-
catenin can be thought of as a scaffolding protein due to the many different proteins that it can 
bind to and recruit in different cellular contexts once bound to TCF/LEF in the nucleus. At the N-
terminus it recruits BCL9 which in turn recruits pygopus, known to be required for transcriptional 
activity in drosophila WNT signaling. The C-terminus recruits many different transcriptional 
activators including the PAF1 complex, mediator complex, RNAPII PIC complex, Brg1, ISW1, 
HATs (TRRAP p400 and TIP60), and the SET1 COMPASS complex (Tomas Valenta et al., 
2012). Competing mechanisms are hypothesized to explain the binding dynamics of the 
abundance of cofactors that are demonstrated to bind to the CTD of β-catenin. First there is the 
ping pong hypothesis, which states that the R11-C and Pygo NHD could provide a ping pong like 
surface to facilitate exchange of cofactors on the C-terminus. Alternatively there could be pools of 
β-catenin bound to various complexes before binding TCF/LEF, these complexes could then 
recruited sequentially. These hypotheses tend to suggest that β-catenin acts broadly to affect the 
transcriptional state of chromatin while interacting with tissue specific transcription factors to elicit 
transcription of target genes (Mosimann, Hausmann, & Basler, 2009a). 
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1.2.7. β-catenin as a transcriptional activator 
Multiple studies have used ChIP-seq to examine the genome wide binding of β-catenin to 
understand its function in disease and development. Aberrant accumulation of β-catenin and 
activation of WNT signaling is the primary cause of colorectal cancer pathogenesis; to that end 
multiple studies have characterized β-catenin binding in cell culture systems of colorectal cancer 
(Bottomly, Kyler, McWeeney, & Yochum, 2010; Fodde, 2002; Schuijers et al., 2014; Watanabe et 
al., 2014). These studies establish a picture of β-catenin regulated genes binding through 
TCF/LEF transcription factors to influence colon carcinogenesis (Schuijers et al., 2014; Watanabe 
et al., 2014). β-catenin ChIP-seq studies in developing xenopus indicate roles for β-catenin as a 
cofactor for binding in gastrointestinal organogenesis and the developing gastrula (Nakamura, de 
Paiva Alves, Veenstra, & Hoppler, 2016; Stevens et al., 2017). Several studies use a human 
pluripotent stem cell derived cell culture system of early development to study β-catenin’s 
transcriptional role in primitive streak development and mesendodermal differentiation (Estarás et 
al., 2015; Funa et al., 2015). Perhaps the most comprehensive view of β-catenin mediated 
transcriptional process is demonstrated by Estaras et al. where they demonstrate that β-catenin 
binds to and regulates the enhancer landscape forming enhancer promoter loops to regulate 
mesendeodermal gene expression (Estarás et al., 2015). β-catenin plays a role in multiple 
aspects of development a role which seems to be conferred by its ability to interact with context 
specific cofactors.  
1.2.8. WNT signaling in Development and Disease 
As evidenced by the many different developmental contexts which β-catenin demonstrated 
in ChIP-seq studies above, WNT signaling play an abundance of critical roles during 
development. This is perhaps best illustrated by the severe phenotypes observed when almost 
any component of WNT signaling is mutated. WNT mutant KOs have been extensively 
characterized in mouse systems. KO of WNT1 results in neural crest deficiencies and aberrant 
midbrain patterning (Ikeya, Lee, Johnson, McMahon, & Takada, 1997). Conditional mutation of β-
catenin driven by Wnt1 affects cell fate in the dorsal spinal cord (T. Valenta et al., 2011). While 
KO of WNT1 in conjunction with Wnt4 results in a decrease in thymocyte production (Mulroy, 
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McMahon, Burakoff, McMahon, & Sen, 2002). Wnt3 plays roles in gastrulation and development 
of limbs (Barrow et al., 2003; C. Liu et al., 1999). Wnt3a KO generates mutants similar to Wnt1 
with deficiencies in neural crest derivatives and CNS progenitors (Ikeya et al., 1997). Additionally 
Wnt3a plays roles in development of the hippocampus and in somitogenesis (Aulehla et al., 2003; 
Lee, Tole, Grove, & McMahon, 2000). Wnt4 is required for female germ line development, with its 
loss the mullerian duct is absent and there are defects in adrenal gland development (Vainio, 
Heikkilä, Kispert, Chin, & McMahon, 1999). Wnt5a plays multiple roles in development, including 
limb formation, lung morphogenesis, intestinal elongation, and mammary gland development (C. 
Li, Xiao, Hormi, Borok, & Minoo, 2002; Liang et al., 2003; Yamaguchi, Bradley, McMahon, & 
Jones, 1999; J. Yang, Wu, Tan, & Klein, 2003). Wnt7a deficiency results in infertile females due 
to abnormal development of mullerian duct derivatives (Timmreck, Pan, Reindollar, & Gray, 
2003). Additionally evidence suggests Wnt7a acts as a synaptogenic factor, as its loss delays 
maturation of synapses in the cerebellum (Hall, Lucas, & Salinas, 2000). Wnt11 is known to 
regulate uteric branching in kidney development by directing the development of nephron 
progenitors (Majumdar, Vainio, Kispert, McMahon, & McMahon, 2003; O’Brien et al., 2018). The 
role of many WNTs have been investigated and characterized during development demonstrating 
its near ubiquitous appearance in an abundance of developmental contexts. 
Due to the diverse set of processes in development that WNT signaling regulates, when 
processes in the pathway are misregulated they commonly result in a variety of diseases. Many 
WNT signaling defects result in different types of cancers (Zhan, Rindtorff, & Boutros, 2017). The 
classic example of WNT signaling is in familial adenomatous polyposis (FAP); mutations in APC 
were found to be the cause of this hereditary colon cancer (Kinzler et al., 1991; Nishisho et al., 
1991; Rubinfeld et al., 1993). WNT signaling plays a well-known role in self-renewal and 
differentiation of hematopoietic stem cells (HSCs) (T C Luis, Ichii, Brugman, Kincade, & Staal, 
2012; Tannishtha Reya et al., 2003). Most leukemia is characterized by abnormally high WNT 
signaling, with translocation products in AML frequently positively affecting WNT signaling (Cheng 
et al., 2008; Lane et al., 2011; Lento, Congdon, Voermans, Kritzik, & Reya, 2013; Muller-Tidow et 
al., 2004). WNT signaling additionally plays important roles in skin development (Fuchs, 2007). 
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Hyperactive β-catenin is implicated in melanoma tumor initiation with its decrease unexpectedly 
important in more malignant and metastatic tumors (Lim & Nusse, 2013). WNT signaling is also 
an important factor in breast cancer, with β-catenin mediated Cyclin1 D1 expression implicated in 
formation and progression (Lin et al., 2000). WNT signaling plays roles in many types of cancers’ 
initiation and progression and modulating WNT signaling activity continues to be a main 
therapeutic goal for the cancer field. 
In addition to the many types of cancers caused by misregulated Wnt signaling, there are a 
variety of developmental genetic disorders caused by defects in WNT signaling. Perhaps the 
most striking is the loss of Wnt3a, which results in tetra-amelia syndrome – loss of all four limbs 
(Niemann et al., 2004). Mutations in Wnt1 are linked to osteogenesis imperfecta, a disease 
characterized by reduced bone mass and increased susceptibility to recurrent fractures. 
(Fahiminiya et al., 2013; Keupp et al., 2013; Pyott et al., 2013) SERKAL (SEx Reversion, 
Kidneys, Adrenal, and Lung dysgenesis) syndrome were found to be caused by mutations in 
Wnt4, symptoms are consistent with mouse KO studies including female to male sex reversal and 
disrupted organogenesis. Similarly several disorders characterized by abnormal limb 
development such as Fuhrmann syndrome and AI-Awadi/Raas-Rothschild/Schinzel phocomelia 
syndrome are characterized by mutations in Wnt7, and mouse KO studies demonstrate similar 
phenotypes (Parr & McMahon, 1995; Woods et al., 2006). WNTs play critical roles in 
development and adult homeostasis. Abnormalities in the pathway can result in severe 
developmental disorders and mutations that promote constitutive activation lead to cancers. 
Improved understanding of this complex signaling cascade could improve efforts to develop 
targeted therapeutics to combat the many diseases affected by this pathway.   
1.3. Neural Development 
 “What is perhaps the most intriguing question of all is whether the brain is powerful 
enough to solve the problem of its own creation” (Eichele, 1992). The central nervous system is 
perhaps the most complex of all biological systems with an estimated more than 100 million 
neurons and glial cells forming more than 60 trillion neuronal connections (Stiles & Jernigan, 
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2010; Williams & Herrup, 1988). Here follows a brief outline of the current state of knowledge of 
neural development with an emphasis on the role of WNT signaling in these processes. 
The central nervous system develops from the dorsal epiblast of the vertebrate gastrula 
(Wurst & Bally-Cuif, 2001). Early transplantation of the upper dorsal blastopore lip in amphibians 
by Spemann and Mangold led to the induced formation of a secondary embryo, including a neural 
plate of host cells, implicating the transplant as an organizing factor in neural induction (Spemann 
& Mangold, 2001). Analogous structures have since been identified in chick, fish, rabbit, and 
mouse suggesting a conserved mechanism of induction (Beddington, 1994; Waddington, 1950). 
However the molecular nature of the Spemann-Mangold organizer proved elusive for many years 
after its initial discovery. Eventually it was discovered that the Spemann organizer provided BMP 
antagonism by releasing BMP inhibitors Noggin (Lamb et al., 1993; Smith & Harland, 1992), 
chordin (Sasai, Lu, Steinbeisser, & De Robertis, 1995), and follistatin (Hemmati-Brivanlou, Kelly, 
& Melton, 1994). This led to the idea of a model of default neural induction in the ectoderm, that in 
the absence of BMP signaling neural ectoderm was induced while BMP induced epidermis 
(Muñoz-Sanjuán & Brivanlou, 2002). This idea has since been challenged by studies that 
demonstrate role for FGF in neural induction independent of BMP in both xenopus (Delaune, 
Lemaire, & Kodjabachian, 2005) and chick (Linker & Stern, 2004). The role for WNT signaling is 
still under dispute perhaps due to variable signaling requirements among species (D. Brafman & 
Willert, 2017; Stern, 2005). 
1.3.1. Neural induction 
Several studies have demonstrated in xenopus that WNT signaling is required for neural 
induction (Baker, Beddington, & Harland, 1999; Wessely, Agius, Oelgeschläger, Pera, & De 
Robertis, 2001). In these instances WNT signaling was shown to repress BMP signaling, either 
directly (Baker et al., 1999) or by inducing expression of BMP antagonists (Wessely et al., 2001), 
to cause neural induction. Multiple studies however contradict this earlier work, demonstrating 
that WNT signaling interferes with neural induction and active WNT signaling is not required 
(Glinka et al., 1998; Heeg-Truesdell & LaBonne, 2006; Min, Kriebel, Hou, & Pera, 2011; S. I. 
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Wilson et al., 2001).  Future work could perhaps reconcile these contradictory results, however it 
is well agreed that BMP antagonism results in the neutralization of naïve ectoderm.  
 The sequential two step activation, transformation model of neural induction and 
subsequent patterning was put forth by Nieuwkoop et al. following experiments where competent 
ectoderm was transplanted into different antero-posterior levels of the neural plate (Nieuwkoop, 
1952). This hypothesis has gained considerable support, with the Spemann organizer leading to 
the activation, or induction of neural ectoderm with an anterior fate and a gradient of WNT 
signaling found to specify the regional cell identities along the antero-posterior axis (Kiecker & 
Niehrs, 2001). Ectopic expression of xWnt3a in xenopus animal caps reduced expression of 
anterior neural genes and elevated expression of posterior neural genes, providing the first 
evidence that WNT serves as a transforming posteriorizing factor in specification of regional 
identity of neural progenitors (McGrew, Lai, & Moon, 1995), Loss of function studies using a 
dominant negative form of Xwnt8 supported these results.(Bang, Papalopulu, Goulding, & 
Kintner, 1999; McGrew, Hoppler, & Moon, 1997). Although several different organizer structures 
have been hypothesized over the years to coordinate induction and patterning of the neural tube, 
the source of the WNT gradient that regulates A/P fate has been identified to come from the 
paraxial dorsolateral mesoderm, beneath the developing neural tube (Elkouby et al., 2010). The 
headless (hdl) zebrafish mutant, as its moniker suggests, is missing the anterior neural structures 
including the eyes, forebrain, and part of the neural tube. This phenotype is a result of a mutation 
in TCF3, a negative regulator of WNT signaling, further demonstrating the importance proper 
regulation of WNT signaling in generating a properly patterned neural tube (C. H. Kim et al., 
2000). Additional studies have estabished the importance of WNT inhibition in generation of 
anterior neural structures including Dickkopf-1 (Dkk1) (Glinka et al., 1998; Hashimoto et al., 2000; 
Kazanskaya, Glinka, & Niehrs, 2000; Kimura-Yoshida et al., 2005; Mukhopadhyay et al., 2001) 
and secreted frizzled receptor proteins (SFRPs) (Kemp, Willems, Abdo, Lambiv, & Leyns, 2005; 
Leyns, Bouwmeester, Kim, Piccolo, & De Robertis, 1997; Mii & Taira, 2009). 
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1.3.2. WNT and patterning of the forebrain 
As previously discussed, WNT inhibition is required for forebrain development and this 
requirement continues for patterning of the telencephalon (giving rise to the cerebral cortex), 
while the more posterior diencephalon (giving rise to the thalamic tissues) requires local WNT 
signaling to elicit the appropriate cell fate (S. W. Wilson & Houart, 2004). Several studies have 
demonstrated the need for repression of WNT signaling for proper telencephalon development, 
when WNT signaling is high due to ectopic expression or genetic mutations, telencephalic identity 
is repressed and an expanded diencephalon is observed (R. Quinlan, Graf, Mason, Lumsden, & 
Kiecker, 2009). WNT signaling also is known to affect dorsal (pallidal) vs ventral (subpallidal) cell 
fates in the developing forebrain, with higher levels of WNT signaling corresponding to correct 
dorsal patterning (Campbell, 2003; Gulacsi & Anderson, 2008; Gunhaga et al., 2003). The dorsal 
telencephalon develops into the cerebrum, part of which is composed of the hippocampus 
(Hébert & Fishell, 2008). WNT signaling is a demonstrated requirement for hippocampus 
development (Galceran, Miyashita-Lin, Devaney, Rubenstein, & Grosschedl, 2000; Lee et al., 
2000). A proper balance of repression and activation of WNT signaling is necessary for forebrain 
patterning. 
1.3.3. WNT and patterning of the midbrain 
Specification of midbrain structures is strongly dependent on WNT1 expression, as mouse 
knockout studies of this gene have demonstrated dramatic loss of midbrain and rostral hindbrain 
structures (A P McMahon, Joyner, Bradley, & McMahon, 1992; Andrew P. McMahon & Bradley, 
1990; K R Thomas & Capecchi, 1990; Kirk R. Thomas, Musci, Neumann, & Capecchi, 1991). 
Later studies have shown that the isthmic organizer or midbrain hindbrain boundary is a key 
organizer regulating formation of the midbrain and anterior hindbrain, a balance dependent both 
WNT and FGF signaling (C. Guo et al., 2007; H. Harada, Sato, & Nakamura, 2016; Rhinn & 
Brand, 2001). Conditional knockout of b-catenin under the Wnt1 regulatory sequence provided 
supporting evidence of the role of Wnt1 in the formation of the midbrain and cerebellum and an 
unexpected function in craniofacial development suggesting a role in neural crest development 
(Brault et al., 2001). Future work further examined the role of β-catenin in midbrain development 
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by creating β-catenin mutations in the N- and C- termini to examine the effects of β-catenin in 
adhesion vs. transcriptional activation in midbrain development (Tomas Valenta et al., 2011). 
Disruption of the signaling ability of β-catenin resulted in reduced expression of Pax3 and Sox2 in 
the dorsal neural tube, demonstrating the importance of β-catenin transcription in mediating cell 
fate decisions in the dorsal neural tube (Tomas Valenta et al., 2011).  
1.3.4. WNT and patterning of the hindbrain 
WNT also plays important roles in the generation of the hindbrain and spinal cord. Wnt3a 
has been shown to activate meis3, a critical transcription factor required for hindbrain induction 
(Elkouby et al., 2010; Elkouby, Polevoy, Gutkovich, Michaelov, & Frank, 2012). In the absence of 
WNT signaling Meis3 is able to induce hindbrain generation (Elkouby et al., 2010). Although WNT 
signaling is essential for generation of initial patterning of hindbrain structures; future subdivisons 
are refined based on FGF and RA signaling (Esain, Postlethwait, Charnay, & Ghislain, 2010; 
Ishioka et al., 2011; Mazzoni et al., 2013; Partanen, 2007). Similarly to its action in the hindbrain, 
WNT signaling also regulates induction and patterning of the spinal cord (D. Brafman & Willert, 
2017). WNT action in spinal cord generation is thought to act through CDX transcription factors, 
which serve as the central mediators of the gene regulatory network in the spinal cord (Lohnes, 
2003). CDX genes are direct WNT targets with TCF/LEF binding sites in their gene regulatory 
regions (Haremaki, Tanaka, Hongo, Yuge, & Okamoto, 2003; Lickert & Kemler, 2002; Pilon, Oh, 
Sylvestre, Savory, & Lohnes, 2007; Prinos et al., 2001; W. C. H. Wang & Shashikant, 2007). In 
fact, similar to Meis3 activity in the hindbrain CDX2 can substitute for WNT to induce 
caudalization of neural cells to a spinal cord fate (Metzis et al., 2018). 
WNT signaling plays roles in induction, initial A/P patterning, and further refinement of 
subdivisons of the developing neural tube. Therefore it is not surprising that aberrant WNT 
signaling can lead developmental disorders. Both canonical and non-canonical WNT signaling 
are implicated in neural tube defects (NTD) that can lead to conditions such as spina bifida, 
anencephaly, and craniorachischisis (Mulligan & Cheyette, 2012). Additionally mutations in the 
WNT signaling pathway have been implicated in a variety of psychiatric disorders, including 
autism spectrum disorder (ASD) (Gilman et al., 2011; Krumm, O’Roak, Shendure, & Eichler, 
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2014; P.-M. Martin et al., 2013; Mohn et al., 2014; O’Roak et al., 2012; Turner et al., 2016; 
Wassink et al., 2001), schizophrenia (Hoseth et al., 2018; Panaccione et al., 2013), and bipolar 
disorder (BD) (Muneer, 2017; Valvezan & Klein, 2012). Emerging cerebral organoid technologies 
offer the opportunity to study the effects of these various mutations during neural development to 
understand how mutations in the WNT signaling pathway may be implicated in the organization of 
brain structures leading to psychiatric disorders (Hansen Wang, 2018; Wen, Christian, Song, & 
Ming, 2016). 
1.4. Chromatin and Epigenetics 
The first use of the term epigenetics can be attributed to C.H. Waddington, where he 
defined it as the ‘causal mechanism by which the genes of the genotype bring about phenotypic 
effect’ (Waddington, 2012). The definition of epigenetics has since been expanded and refined, 
which has led to diverging definitions at times (Deans & Maggert, 2015; David Haig, 2012). The 
differences in definitions ascribed to epigenetics could be due to the dual origins of the word (D 
Haig, 2004). In the original sense the term described two concepts that Waddington pioneered, 
phenotypic plasticity and canalization (Deans & Maggert, 2015). Phenotypic plasticity refers to the 
ability of individual genotypes to produce different phenotypes (Pigliucci, Murren, & Schlichting, 
2006). Canalization describes the property of stability of phenotype across different genotypes 
and environments. (Waddington, 1959) Some years later David Nanney described epigenetics as 
a cellular control system separate from the genotype that consisted of supporting mechanisms to 
control the expression of specific genes that persist after cell division (Deans & Maggert, 2015; 
Nanney, 1958). Following studies examining cellular memory and DNA methylation, Holliday 
proposed a new definition of epigenetics as nuclear inheritance, not based on differences in DNA 
sequence (Holliday, 1994). This definition was refined by Wu and Morris as the study of changes 
in gene function that are mitotically or meiotically heritable and that do not entail change in DNA 
sequence (Wu Ct & Morris, 2001). It is this definition that the following work will focus on. 
1.4.1. The structure and organization of chromatin 
Chromatin is the complex of DNA and protein located in the nucleus that compacts DNA to 
regulate which genes are transcribed into RNA is a cell type specific way (Perino & Veenstra, 
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2016). The proteins that complex with DNA to form chromatin are histones, these were originally 
thought to act generally as inhibitors of transcription. (Huang & Bonner, 1962; Stedman & 
Stedman, 1950) X-ray and biochemical analysis revealed histones to form an octamer of two 
repeating units composed of the main four histones, H2A, H2B, H3, and H4 around which was 
wrapped about 200 bp of DNA. This repeating structure is known as a nucleosome (Kornberg, 
1974, 1977; Kornberg & Thomas, 1974). X-ray crystallography studies provided detailed analysis 
of the structure of nucelosomes revealing that each histone consists of a three-helix domain 
known as the histone fold as well as two unstructured tails (K Luger, Mäder, Richmond, Sargent, 
& Richmond, 1997; Rhodes, 1997; Richmond, Finch, Rushton, Rhodes, & Klug, 1984). Each core 
octamer is connected by the linker histone H1 that binds 20 to 75 bp of DNA, which is thought to 
stabilize higher-order chromatin structures (Allan, Hartman, Crane-Robinson, & Aviles, 1980; 
Oudet, Gross-Bellard, & Chambon, 1975; Woodcock, Skoultchi, & Fan, 2006). The repeating 
‘beads on a string’ structures formed by nucelosomes impedes transcription of DNA by physical 
obstruction and bending the DNA to reduce availability to transcription (K Luger et al., 1997). 
Chromatin has long been described has having hierarchical structures with progressively 
higher order and more densely compacted structures (Grigoryev, 2018; Ou et al., 2017). As 
described above the smallest unit is the 11 nm DNA-core nucleosome structure, these assemble 
into 30 nm fibers, then 120 nm chromonema, 300-700 nm chromatids, and finally the most 
condensed structural form occurs the in metaphase chromosomes (Ou et al., 2017). Recent 
studies however question this hierarchical structure hypothesis, as several imaging technologies 
have been unable to visualize this different sized fibers (Eltsov, Maclellan, Maeshima, Frangakis, 
& Dubochet, 2008; Fussner et al., 2012; Nishino et al., 2012). The development of a novel 
imaging technology called ChromEMT has allowed visualization of fixed chromatin in the cell 
nucleus, in comparison to previous studies which were based on chromatin that had been 
reassembled in vitro by reconstituting purified DNA and histones (Ou et al., 2017). This 
technology has revealed that chromatin in cells doesn’t tend to form a hierarchical structure and 
instead adopts a disordered 5 to 24 nm diameter chain packed together at different densities 
throughout the nucleus (Ou et al., 2017). Future work visualizing intact chromatin could enable 
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the direct mapping of proteins in chromatin providing great insight into the way chromatin 
structure is regulated and suggesting mechanisms for manipulation (Larson & Misteli, 2017). 
1.4.2. Chromatin structure as a mechanism of transcriptional control 
Chromatin is generally thought of as in an open or closed state relative to transcription, 
these are known as euchromatin or heterochromatin respectively (Perino & Veenstra, 2016). 
Euchromatin and heterochromatin states are regulated by the density of nucelosomes, histone 
variant incorporation, and post transcriptional modifications (PTM) of histone tails and body 
(Karolin Luger, 2006). The density of nucleosomes can be controlled by ATP dependent 
chromatin remodeling complexes (Clapier, Iwasa, Cairns, & Peterson, 2017). Additionally 
chromatin state can be controlled by histone variants incorporated into the core nucleosome 
structure (Karolin Luger, 2006; Widom, 1998). For example the histone variant H2A.Z is more 
amenable to compaction than the canonical H2A variant (Fan, Gordon, Luger, Hansen, & 
Tremethick, 2002). Finally there are PTMs of histone N-terminal tails which can affect histone-
DNA or histone-histone contacts to influence chromatin accessibility (Bowman & Poirier, 2015). 
Acetylation of H3 on lysine residues is perhaps the most well studied example of this 
phenomenon, a mark that is associated with increased transcription at promoters due to the 
charge of the acetyl group repelling DNA from the nucleosome core (Brownell et al., 1996; 
Grunstein, 1997; Taunton, Hassig, & Schreiber, 1996). The role of common PTMs has been 
extensively characterized, including acetylation, methylation, phosphorylation, ubiquitylation, 
sumoylation and ADP-ribosylation (Bannister & Kouzarides, 2011; Rothbart & Strahl, 2014; 
Wozniak & Strahl, 2014). The diversity of PTMs that can be deposited on both histone tails and 
globular domains give rise to a complex histone code which influences chromatin structure and 
thus transcriptional availability of DNA (Janssen, Sidoli, & Garcia, 2017). 
PTMs are dynamic reversible modifications that are deposited by enzymes known as 
histone writers and removed by histone erasers (Gillette & Hill, 2015). Readers and writers are 
separated into classes based on the specific PTM that they regulate. Additionally there are 
histone readers which are proteins that recognize PTMs to effect specific transcriptional 
outcomes (Yun, Wu, Workman, & Li, 2011). Lysine acetylation is one of the most characterized 
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PTMs, it is deposited by histone acetyltransferases (HATs) and removed by histone deacetlyases 
(HDACs) (Yun et al., 2011). Acetylated lysines are recognized by bromodomains, which regulate 
initiation and elongation of transcription (Dhalluin et al., 1999; Josling, Selvarajah, Petter, & Duffy, 
2012). Lysine methylation is another of the most common PTMs present in cells, there are four 
types of methylated marks: unmethylated, mono- (me1), di (me2), and tri- (me3) methylation (Yun 
et al., 2011). These marks are regulated by histone methyltransferases (HMTs) and histone 
demethylases (HDMs) (Teperino, Schoonjans, & Auwerx, 2010). The four types of methylation 
that can be present on histones are recognized by many different types of protein domains 
including chromo, WD40, Tudor, double/tandem Tudor, MBT, Ankyrin Repeats, zf-CW, and 
PWWP domains (Yun et al., 2011). The general transcription factor TFIID, important in the 
assembly of the pre-initiation complex, additionally recognizes H3K4me3 (Vermeulen et al., 
2010). Just as more PTMs continue to be discovered, information on writers, erasers, and 
readers of additional PTMs continues to be an area of active investigation.  
hESCs have a globally open chromatin state with less heterochromatin and more active 
chromatin domains than differentiated cells (Azuara et al., 2006; Guenther, Levine, Boyer, 
Jaenisch, & Young, 2007; Lister et al., 2009; Meissner et al., 2008; Park et al., n.d.). 
Developmental genes in the ES state are also simultaneously marked with active (H3K4me3) and 
repressive (H3K27me3) marks at developmental genes, these genes described as bivalent and 
thought to be poised for expression (Azuara et al., 2006; Bernstein et al., 2006). As ES cells 
differentiate bivalent genes are resolved and become mono-valent, either active or repressed 
(Mikkelsen et al., 2007). Multiple studies have examined how chromatin profiles changes as cells 
adopt a more differentiated state, revealing the complex interplay of transcription factor binding, 
enhancer occupancy, and transcriptional state of developing cells (Dixon et al., 2015; Dowen et 
al., 2014; Heintzman et al., 2009; Ji et al., 2016; Tsankov et al., 2015; A. Wang et al., 2015; Xie et 
al., 2013). It’s important to understand both genetic and epigenetic changes occurring during 
development, as most common variation in the human genome doesn’t always affect protein 
coding genes, suggesting the effects of these differences could be attributed to changes in 
epigenetic state (Khurana et al., 2013).  
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The transcriptome of the developing and adult human brain has been characterized in 
some detail, outlining genetic circuits that underpin human neural development (Hawrylycz et al., 
2012; Kang et al., 2011; Konopka et al., 2012; Miller et al., 2014; Silbereis, Pochareddy, Zhu, Li, 
& Sestan, 2016). Some enhancer networks have been identified in adult human brain, however 
information regarding the dynamic changes in chromatin structure during neural development 
have not yet been mapped (Vaidya & Chakradhar, 2014). Changes in histone occupancy at 
genetic elements such as enhancers are thought to contribute to cell competence, therefore 
affecting transcription factor occupancy and cell differentiation (Buecker & Wysocka, 2012; Metzis 
et al., 2018; A. Wang et al., 2015). Human ES and iPSC models of neural development will allow 
interrogation of epigenetic changes during neural development to enhance our understanding of 
how the epigenetic landscape is altered in healthy and diseased states during development 
(Lancaster et al., 2013). 
1.5. Specific Aims 
We propose to complete this study through the following specific aims:  
1.5.1. Specific Aim1 
Development and characterization of an in vitro model of neural patterning using human 
pluripotent stem cells 
1.5.2. Specific Aim2 
Characterization of the role of β-catenin in regulating fate decisions of human neural 
progenitor cells in neural patterning 
1.5.3. Specific Aim3 
Characterization of the role of negative regulators of WNT signaling regulating fate 
decisions of human neural progenitor cells in neural patterning 
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CHAPTER 2 
DEVLOPMENT OF AN IN VITRO MODEL OF NEURAL DEVELOPMENT USING WNT 
SIGNALING 
2.1. Introduction 
Neural progenitor cells (NPCs) and neurons derived from human pluripotent stem cells 
(hPSCs) could provide an unlimited source of cells for drug testing and cell-based therapies 
(Koch, Kokaia, Lindvall, & Brüstle, 2009; S.-C. Zhang, Li, Johnson, & Pankratz, 2008). In addition, 
these cells provide a unique opportunity to explore complex neural development in a simplified 
and accessible system. Current protocols for differentiating hPSCs toward specific neuronal 
lineages result in a mixture of neurons from various regions of the CNS, which limits the use of 
these cells for cell-based therapies, disease modeling, and developmental studies that require 
uniform populations of neurons. However, the precise source of this heterogeneity in neuronal 
cultures has yet to be resolved. 
Differentiation of stem and progenitor populations is largely governed by the heterogeneity 
present in these cultures, which ultimately determines their differentiation bias. For example, 
several studies have found subpopulations with distinct self-renewal and differentiation potentials 
in hematopoietic (Dykstra et al., 2007; S. Huang, Guo, May, & Enver, 2007) and intestinal 
(Sangiorgi & Capecchi, 2008) stem cells. Likewise, heterogeneous expression of pluripotency-
related transcription factors and other cell-surface markers bestows distinct lineage-specific 
differentiation propensities on hPSCs (Drukker et al., 2012; Hong et al., 2011; Narsinh et al., 
2011; Stewart et al., 2006; Wu & Tzanakakis, 2012). In contrast, NPCs derived from hPSCs have 
been considered to be a homogeneous cell population, and it has been suggested that their 
differentiation to neuronal cultures can be biased and manipulated by altering culture conditions 
(Dottori & Pera, 2008a; Gaspard & Vanderhaeghen, 2010a; Germain, Banda, & Grabel, 2010; Y. 
Jiang, Zhang, & Hu, 2012; H. Liu & Zhang, 2011; Nat & Dechant, 2011; Peljto & Wichterle, 2011; 
S. C. Zhang, 2006). Our study challenges this simplistic view of neuronal differentiation in hPSC 
cultures. 
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We demonstrate that hPSC-derived NPCs, like other stem and progenitor populations, are 
heterogeneous and display a bias in their differentiation potential. Through the use of WNT 
reporter hPSC lines, we identified endogenous WNT signaling as a primary regulator of this 
heterogeneity in NPC and neuronal cultures. Flow cytometry (FC)-based purification and genetic 
assessment of reporter-expressing cell types revealed that the identity and differentiation 
potential of hPSC-derived NPCs are directly related to the level of endogenous WNT signaling 
present in these cell types. Through exogenous manipulation of WNT signaling, we were able to 
reduce NPC heterogeneity and generate cultures of regionally specific progenitors and neurons. 
Overall, this study demonstrates that WNT signaling plays an important role in deriving regionally 
homogeneous populations of NPCs and neurons, thereby greatly improving their scientific and 
therapeutic utility. 
2.2. Experimental Methods 
2.2.1. Cells and culture conditions 
All media components were from Life Technologies unless otherwise noted. For hPSC 
culture, the following media were used: mouse embryonic fibroblast (MEF) (1X high glucose 
DMEM, 10% fetal bovine serum, 1% (v/v) L-glutamine penicillin/streptomycin). H9/HES3/RiPSC 
hPSCs (1X DMEM-F12, 20% (v/v) Knockout Serum Replacement, 1% (v/v) non-essential amino 
acids, 0.5% (v/v) glutamine, 120 µM 2-mercaptoethanol [Sigma]). HUES9 (1 x Knockout DMEM, 
10% (v/v) Knockout Serum Replacement, 10% (v/v) human plasmanate (Chapin Healthcare, 
Anaheim CA, USA) 1% (v/v) non-essential amino acids, 0.5% (v/v) glutamine, 55 µM 2-
mercaptoethanol [Sigma]); All hPSC lines were maintained on feeder layers of mitotically 
inactivated MEFs (2x104 /cm2 ; Millipore). All hPSC cultures were supplemented with 30 ng/ml 
FGF2 (Life Technologies). MEF-CM was produced by culturing hPSC medium on MEFs for 24 hr 
followed by sterile filtering. Cells were routinely passaged with Accutase (Millipore), washed, and 
replated at a density 4.25 x 104 /cm2 . 
2.2.2. Generation of Wnt reporter hESCs 
The lentiviral construct that was used to generate the WNT reporter line contained a 
7xTCF-eGFP construct and puromycin resistance gene. (Fuerer & Nusse, 2010) High titer 
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lentivirus was produced as previously described (Miyoshi, Blömer, Takahashi, Gage, & Verma, 
1998; Zufferey et al., 1998). HUES9 hESCs were infected overnight with lentivirus. Infected pools 
were selected with puromycin (0.5 µg/ml) for 2 weeks. For generation of clonal hESC lines, 
transduced pools were then treated with 200 ng/ml purified mouse WNT3a for 48 hours. Cells 
were dissociated with Accutase for 5 min at 37°C, triturated, and passed through a 40 µm cell 
strainer. Cells were then washed twice with FACS buffer (PBS, 10 mM EDTA, and 2% FBS) and 
resuspended at a maximum concentration of 5 x 106 cells per 100 ul. Single TOP-GFP+ cells 
were sorted into a Matrigel (BD)-coated 96 well plated with MEF-CM supplemented with 5 µM 
ROCK inhibitor Y27632 (Stemgent) and 30 ng/ml FGF2. After expansion, a total of 45 clones 
were screened for: (1) robust TOP-GFP expression upon WNT3a stimulation and (2) normal 
euploid karyotype. 
2.2.3. Neural progenitor cell (NPC) generation, expansion, and differentiation 
To initiate neural differentiation, hPSCs were cultured on Matrigel (BD Biosciences) in 
MEF-CM supplemented with 30 ng/ml FGF2 or TeSRTM2 (Stem Cell Technologies). Cells were 
then detached with treatment with Accutase (Millipore) for 5 min and resuspended in neural 
induction media (1% N2/1% B27 without vitamin A/DMEM:F12) supplemented with 5 µM Y-
267632 (Stemgent), 50 ng/ml recombinant mouse Noggin (R&D Systems), 0.5 µM Dorsomorphin 
(Tocris Bioscience)]. Next, 7.5 x 105 cells were pipetted to each well of a 6-well ultra low 
attachment plates (Corning). The plates were then placed on an orbital shaker set at 95 rpm in a 
37°C/5% CO2 tissue culture incubator. The next day, the cells formed spherical clusters 
(embryoid bodies [EBs]) and the media was changed to neural induction media with 50 ng/ml 
recombinant mouse Noggin and 0.5 µM Dorsomorphin. The media was subsequently changed 
every other day. After 5 days in suspension culture, the EBs were then transferred to a 10 cm 
dish coated (3 x 6 wells per 10 cm dish) with growth factor reduced Matrigel (1:25 in KnockOut 
DMEM; BD Biosciences) for attachment. The plated EBs were cultured in neural induction media 
with 50 ng/ml recombinant mouse Noggin and 0.5 µM Dorsomorphin for an additional 7 days. 
Neural rosettes were cut out by dissection under an EVOS (Life Technologies) microscope. 
Dissected rosettes were incubated in Accutase for 5 min and then triturated to single cells with a 
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1 mL pipet. Rosettes were then plated onto poly-Lornithine (PLO; 10 µg/mL; Sigma) and mouse 
laminin (Ln; 5 µg/mL; Sigma) coated dishes at a density of 12,500 cells/cm2 in neural induction 
media supplemented with 10 ng/mL mouse FGF2 and 10 ng/ml mouse EGF2 (R&D Systems). 
IWP2 (Stemgent) and CHIR 98014 (CHIR; Axon Medchem) were added 2 days after EB 
formation. For routine maintenance, NPCs were passaged onto PLO/Ln coated plates at a 
density of 10,000 cells/cm2 in neural induction media supplemented with 10 ng/mL mouse FGF2 
and 10 ng/ml mouse EGF2. TOP-GFP sorted as well as IWP2- and CHIR-treated NPCs were 
derived and maintained in the absence of FGF2 and EGF2. For neuronal differentiation, NPCs 
were dissociated with Accutase for 5 min at 37°C, triturated, and plated onto PLO/Ln coated 
plates at a density of 100,000 cells/cm2. Cells were cultured in neuronal differentiation media 
(0.5% N2/0.5% B27 without vitamin A/DMEM:F12) supplemented with 20 ng/ml BDNF (R&D 
Systems), 20 ng/ml GDNF (R&D Systems), 1 µM DAPT (Tocris Bioscience), and 0.5 mM , 
dibutyrl-cAMP (db-cAMP; Sigma) for 4 weeks. 
2.2.4. Quantitative PCR (qPCR) 
RNA was isolated from cells using TRIzol (Life Technologies), and treated with DNase I 
(Life Technologies) to remove traces of genomic DNA. Reverse transcription was performed with 
qScript cDNA Supermix (Quanta Biosciences). Quantitative PCR was carried out using TaqMan 
probes (Life Technologies) and TaqMan Fast Universal PCR Master Mix (Life Technologies) on a 
7900HT Real Time PCR machine (Life Technologies), with a 10 min gradient to 95°C followed by 
40 cycles at 95°C for 15s and 60°C for 1 min. Taqman gene expression assay primers (Life 
Technologies; Table S4) were used. Gene expression was normalized to 18S rRNA levels. Delta 
Ct values were calculated as Ct target– Ct18s. All experiments were performed with three 
technical replicates. Relative fold changes in gene expression were calculated using the 2-ΔΔCt 
method. Data are presented as the average of the biological replicates ± standard error of the 
mean (S.E.M). 
2.2.5. Immunofluorescence 
Cultures were gently washed twice with staining buffer (PBS w/ 1% (w/v) BSA) 
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prior to fixation. Cultures were then fixed for 15 min at room temperature (RT) with fresh 
paraformaldeyde (4% (w/v)). The cultures were washed twice with staining buffer and 
permeabilized with 0.2% (v/v) Triton-X-100 in stain buffer for 20 min at 4°C. Cultures were then 
washed twice with staining buffer. Primary antibodies were incubated overnight at 4°C and then 
washed twice with stain buffer at RT. Secondary antibodies were incubated at RT for 1 hr. 
Antibodies used are listed in Table S5. Nucleic acids were stained for DNA with Hoechst 33342 
(2 µg/ml; Life Technologies) for 5 min at room temperature. Imaging was performed using an 
automated confocal microscope (Olympus Fluoview 1000 with motorized stage). Quantification of 
images was performed by counting a minimum of 9 fields at 20x magnification. Image 
quantification of the data is presented as the average of these fields ± standard deviation (S.D.). 
2.2.6. Flow cytometry and cell replating 
Cells were dissociated with Accutase for 5 min at 37°C, triturated, and passed through a 40 
µm cell strainer. Cells were then washed twice with FACS buffer (PBS, 10 mM EDTA, and 2% 
FBS) and resuspended at a maximum concentration of 5 x 106 cells per 100 ul. One test volume 
of antibody was added for each 100 µl cell suspension (Table S5). Cells were stained for 30 min 
on ice, washed, and resuspended in stain buffer. Cells were analyzed and sorted with a 
FACSCanto or FACSAria (BD Biosciences). Flow cytometry data was analyzed with FACSDiva 
software (BD Biosciences). Isotype negative controls are listed in Table S4. For sorting 
experiments in which cells were separated on the basis of GFP expression, wild-type (WT) non-
fluorescing cells were used as a negative control. For replating experiments, cells were stained 
with appropriate antibodies and sorted into FACS buffer with 5µM Y27632 (Stemgent). Sorted 
cells were replated at the appropriate density and media with 10 µM Y27632 
2.2.7. RNA sequencing (RNA-seq) 
Total RNA from FACS sorted TOP-GFP+ and TOP-GFP- NPCs were isolated, depleted of 
genomic DNA and rRNA and fragmented to ~200 bp by RNase III. After ligating the Adaptor Mix, 
fragmented RNA was converted to the first strand cDNA by ArrayScript Reverse Transcriptase 
(Ambion), size selected (100-200bp) by gel electrophoresis, and amplified by PCR using adaptor-
specific primers. Deep sequencing was performed on an Illumina Genome Analyzer II. Analysis of 
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genome-wide expression data was performed as previously described (Trapnell et al., 2013, 
2012). Briefly, raw reads from two biologically independent samples were aligned to the reference 
human genome (hg19) using TopHat. Cufflinks was used to assemble individual transcripts from 
the mapped reads. Cuffmerge was used to merge the assembled transcripts from the two 
biologically independent samples. Cuffdiff was used to calculate gene expression levels and test 
for the statistical significance of differences in gene expression. Reads per kilobase per million 
mapped reads (RPKM) were calculated for each gene and used as an estimate of expression 
levels. 
2.3. Results and Discussion 
2.3.1. Endogenous WNT Signaling is a major source of heterogeneity in NPCs 
derived from hPSCs 
It is well established that WNT signaling regulates the regional identity along the anterior-
posterior (A/P) axis of the developing CNS. To explore the possibility that WNT signaling exerts 
similar effects in a cell-culture-based system of neural development, we generated clonal human 
embryonic stem cell (hESC) lines (HUES9) carrying a stably integrated GFP reporter under the 
control of a WNT-responsive promoter, called TCF Optimal Promoter (TOP) (Fuerer & Nusse, 
2010) (Figure A.1A). In undifferentiated hESCs, this reporter is inactive but expresses GFP upon 
stimulation with recombinant WNT3a (Figure A.1B). In contrast to a previous study (Blauwkamp, 
Nigam, Ardehali, Weissman, & Nusse, 2012), none of our clones or the nonclonal pool expressed 
GFP in the absence of exogenous WNT3a. This likely reflects the heterogeneity among hESC 
lines, especially with respect to endogenous expression of WNT3 (W. Jiang, Zhang, Bursac, & 
Zhang, 2013). In a subsequent analysis we focused on one clone, clone 19 (hTOP-19), which 
exhibited robust GFP expression upon WNT3a stimulation (nearly 100%; Figure A.1B), displayed 
a normal female karyotype of 46 chromosomes (Figure A.1C), and responded to various 
concentrations of exogenously added WNT3a (Figure A.1D) and chemical inhibitors of GSK3β, 
such as BIO (Figure A.1E). 
Upon differentiation of this WNT reporter line to NPCs (D. A. Brafman, 2015) (Figure A.2A), 
we observed a heterogeneous pattern of GFP expression in the absence of any exogenously 
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added WNT proteins (Figure 2.1A). Despite uniform expression of the pan-neural markers SOX1, 
SOX2, and NESTIN (Figures A.2B and A.2C), and cell morphology (Figure A.2D), FC revealed 
that GFP expression peaked upon rosette formation and a stable population of GFP-positive 
(GFP+) cells persisted through subsequent NPC passages (Figure 2.1B). Addition of WNT3a to 
these NPC cultures resulted in uniformly high GFP expression, thereby demonstrating a 
homogeneous response to WNT signaling in this clonally derived population (Figure A.1F). 
Furthermore, inhibiting endogenous WNT signaling with IWP2, a small molecule that acts on 
PORCN to block WNT processing and subsequent secretion (B. Chen et al., 2009), eliminated 
GFP expression, confirming that reporter expression was due to endogenous WNT signaling 
(Figure A.1F). 
	
Figure 2.1 NPCs are heterogeneous with respect to endogenous WNT signaling A) Phase 
contrast and fluorescent images of WNT reporter hESCs during neural differentiation (EB, scale 
bar, 500 µm; rosette and NPC, scale bar, 200 µm). B) FC of WNT reporter hESCs during neural 
differentiation. No detectable GFP signal was observed in hESCs, but upon differentiation to 
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NPCs, a range of GFP expression patterns was observed. A population of GFP+ cells endured 
through multiple NPC passages. C) Passage 5 reporter-expressing NPCs were separated by FC 
on the basis of GFP expression. A scatterplot of log10 RPKM in GFP+ and GFP− NPCs is 
shown. Genes with statistically significant differences in expression are shown in red. D and E) 
Selection of differentially expressed genes highlighting differences in gene-expression patterns 
related to (D) WNT signaling and (E) A/P patterning and differentiation of the neural tube. 
Consistent with this heterogeneous expression of WNT reporter activity and with previously 
published studies (Dottori & Pera, 2008b; Gaspard & Vanderhaeghen, 2010b; Germain et al., 
2010; H. Liu & Zhang, 2011; Nat & Dechant, 2011; Peljto & Wichterle, 2011), we found that NPCs 
derived under this protocol exhibited significant heterogeneity with respect to regionally specific 
markers (Figures A.2E–A.2H) despite uniform expression of the pan-neural markers SOX1 and 
SOX2 (Figures A.2B and A.2C). For example, these NPCs expressed markers of all A/P regions, 
including the forebrain (FOXG1 and DLX2), forebrain/midbrain (OTX2), midbrain/hindbrain (EN1 
and IRX3), and hindbrain/spinal cord (HOXB4) (Figure A.2E). Moreover, single-cell analysis by 
FC and immunofluorescence (IF) revealed that our NPC cultures heterogeneously expressed the 
regionally specific markers FORSE-1 (Figure A.2F; forebrain), PAX6 (Figure A.2G), and HOXB4 
(Figure A.2H). Together, these data suggested that these in vitro NPC cultures, as in the 
developing embryo, are exposed to patterning cues that impart distinct regional identities and 
neuronal differentiation potentials (Pevny, Sockanathan, Placzek, & Lovell-Badge, 1998; 
Uwanogho et al., 1995; Wood & Episkopou, 1999). Additionally, we confirmed that these NPCs 
were able to differentiate to neurons (Figures A.2I–A.2K), including those with a GABAergic 
identity (Figure A.2J), and glial cells (Figure A.2K). 
To investigate the extent to which the high degree of heterogeneity in A/P positional identity 
correlated with our observed heterogeneity in WNT reporter activity, we performed whole 
transcriptome RNA sequencing (RNA-seq) on sorted GFP+ and GFP-negative (GFP−) NPCs 
from passage 5 NPC cultures (Table A.1). Overall, we identified 1,273 genes with statistically 
significant differential expression between these two cell populations, with expression of 707 
genes being elevated in the GFP+ population and 566 genes elevated in the GFP− population 
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(Figure 2.1C; Table A.1). As expected, WNT target genes such as SP5, LEF1, and AXIN2 were 
elevated in the GFP+ population (Figure 2.1D; Table A2). Additional analysis of WNT pathway 
components revealed that expression of the majority of WNT proteins and agonists was higher in 
GFP+ NPCs, whereas expression of WNT antagonists was higher in GFP− NPCs (Figure 2.1D; 
Table A.2). 
Furthermore, expression of genes with distinct domains of expression along the A/P axis 
segregated into these two cell populations (Figure 2.1E; Table A.3). Specifically, we found that 
GFP− NPCs in clone hTOP-19 were enriched for forebrain/anterior-specific markers such as 
LHX8, DLX2, FOXG1, and LHX2. Conversely, the expression of hindbrain/posterior-related 
markers such as GBX2, PITX2, FGF8, and IRX3 was increased in GFP+ NPCs. Most notably, 
members of the HOX gene family, which are highly expressed in the hindbrain and spinal cord, 
were significantly upregulated in the GFP+ cell population. Finally, various midbrain-associated 
genes such as EN1, EN2, LMX1A, and LMX1B were expressed in both populations. Collectively, 
this RNA-seq analysis establishes a correlation between cells that receive a WNT signal (i.e., the 
GFP+ population) and posterior fates. In contrast, NPCs that do not receive an endogenous WNT 
signal input (i.e., the GFP− population) are biased toward an anterior identity. 
To further characterize the diversity of cells expressing varying levels of GFP in the hTOP-
19 NPCs, we used FC to isolate GFPHIGH, GFPMID, and GFPLOW populations (Figure 2.2A). After 
cell sorting, the specific level of GFP expression remained stable in subsequent culture (Figure 
2B). As expected, expression of the WNT target gene AXIN2 was highest in the GFP HIGH cell 
population and lowest in the GFPLOW NPCs (Figure 2.2C). The three sorted cell populations 
expressed similar levels of the pan-neural markers SOX1, SOX2, and NESTIN (Figures 2D, S3A, 
and S3B), demonstrating that NPCs of varying endogenous WNT activity are homogeneous with 
respect to expression of pan-neural markers. 
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Figure 2.2 Characterization of WNT Reporter Expressing NPC Populations Reveals a Regional 
Bias A) WNT reporter NPCs were divided into three populations on the basis of GFP expression: 
GFPLOW, GFPMID, and GFPHIGH. B) Fluorescent images of GFP-sorted NPC populations. GFP 
expression remains stable after sorting and subsequent culture (scale bar, 100 µm). C) Gene 
expression of the WNT target gene AXIN2 in GFP-sorted NPC populations (mean ± SEM, n = 3 
independent experiments). D) FC of the pan-neural markers NESTIN, SOX1, and SOX2 in GFP-
sorted NPC populations. E) Schematic of areas of expression of key genes involved in A/P 
patterning of the developing neural tube. F) Gene-expression analysis of A/P-related genes in 
GFP-sorted NPC populations (mean ± SEM, n = 3 independent experiments). Populations were 
compared using Student’s t test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. G) IF of A/P-related markers 
in GFP expression in GFPLOW, GFPMID, and GFPHIGH (scale bar, 100 µm). H and I) FORSE-1 and 
(I) PAX6 expression in unsorted and sorted GFP-expressing NPC populations. Isotype controls 
used are listed in Table S5. NFC, nonfluorescing channel. 
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We examined the A/P expression profile (Figure 2.2E) of NPCs with different levels of 
endogenous WNT signaling by quantitative PCR (qPCR; Figure 2F), IF (Figure 2.2G), and FC 
(Figures 2.2H and 2.2I). Expression of the forebrain markers FOXG1, SIX3, and DLX2 was 
highest in GFPLOW NPCs. Expression of OTX2, which is expressed at the forebrain-midbrain 
boundary, was similar in the GFPLOW and GFPMID populations but absent in the GFPHIGH NPCs. 
Expression of the midbrain marker LMX1A was highest in the GFPMID population. The 
midbrain/hindbrain boundary markers IRX3 and EN1 were expressed at high levels in both the 
GFPMID- and GFPHIGH-sorted cell populations. The hindbrain markers HOXA2 and HOXB4 were 
highly expressed in the GFPHIGH NPCs and diminished in both the GFPMID and GFPLOW 
populations. Finally, we performed FC on unsorted GFP-expressing hTOP-19 NPCs. This 
analysis demonstrated a negative correlation between GFP levels and expression of the anterior 
neural cell-surface marker FORSE-1 (Figure 2H). (Elkabetz et al., 2008) PAX6, which is 
expressed in the diencephalon and midbrain during early development, was expressed primarily 
in the GFPLOW and GFPMID cell fractions (Figure 2I). Together, these data suggest that the level of 
endogenous WNT signaling correlates with the positional identity of hESC-derived NPCs. 
To determine whether the effect of endogenous WNT signaling on the regional patterning 
of NPCs was stable, we cultured sorted GFPHIGH and GFPLOW populations for ten passages (>50 
days) and examined the expression of A/P-related genes (Figure S3C). Expression of AXIN2 
remained stable in the GFPHIGH NPCs, and AXIN2 expression did not increase in the GFPLOW 
NPCs over ten passages (Figure S3D). During the course of ten passages, the forebrain markers 
FOXG1, SIX3, and OTX2 were expressed in the GFPLOW NPCs, but not in the GFPHIGH NPCs 
(Figure S3E). Conversely, the hindbrain-associated genes IRX3, EN1, and HOXB4 were stably 
expressed in the GFPHIGH NPCs, but were not elevated in the GFPLOW NPCs during the period of 
ten passages (Figure S3E). In sum, these data indicate that the positional identity of NPCs is 
stable during long-term culture. 
2.3.2. The level of endogenous WNT activity instructs the neuronal differentiation 
potential 
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We wanted to determine whether the level of endogenous WNT signaling present in NPCs 
conferred a regional bias as they were expanded and subsequently differentiated to neurons in 
vitro. To address this issue, FC-purified GFPHIGH, GFPMID, and GFPLOW hTOP-19 NPCs were 
expanded for four passages and then differentiated to neurons (Figure 3A). After 4 weeks of 
differentiation, all three cell populations generated cells with a neuronal morphology (Figure S4A). 
Additionally, IF demonstrated that each NPC population yielded similar numbers of MAP2+ and 
B3T+ neurons (Figures A.4B and A.4C). Importantly, gene expression (Figures 2.3B–2.3D) and 
IF analysis (Figure 2.3E) of neurons generated from these different WNT reporter NPC 
populations revealed distinct regional identities. Neurons generated from GFPLOW NPCs 
expressed the highest levels of FOXG1 (a marker of neurons with telencephalic identity), SATB2 
(labels cortical neurons of layers II/III), CTIP2 (expressed by striatal medium spiny neurons), 
EMX1 (a marker for pyramidal neurons of the cerebral cortex), CUX1 (expressed in layer IV-II 
late-born/upper-layer cortical neurons), and TBR1 (labels cortical neurons, especially those 
associated with layer VI). By comparison, GFPMID NPCs differentiated into neurons with a 
midbrain phenotype, including expression of the midbrain GABAergic-associated marker GATA3 
and the midbrain dopaminergic (mDA)-related markers LMX1A/1B (regulate mDA progenitor 
proliferation, specification, and differentiation), NURR1 (specifies neurotransmitter identity of 
mDA neurons), PITX3 (regulates tyrosine hydroxylase [TH] expression in mDA neurons), and TH 
(the enzyme responsible for generation of L-DOPA, which is a precursor for the neurotransmitter 
dopamine). Finally, neurons differentiated from GFPHIGH NPCs expressed the highest levels of 
hindbrain/spinal-cord-associated genes, such as HOXA2, HOXB4, and HOXB6, as well as the 
motor neuron marker MNX1 (also known as HB9). 
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Figure 2.3 Neuronal Differentiation Bias of Sorted GFP-Expressing NPC Populations A) 
Schematic of the experimental protocol. FC was used to sort GFP-expressing NPCs into GFPLOW, 
GFPMID, and GFPHIGH populations. The sorted cell populations were expanded for four passages 
and then differentiated to neurons. B-D) Gene-expression analysis of (B) cortical/forebrain-, (C) 
midbrain-, and (D) hindbrain/spinal-cord-related neuronal genes in neurons derived from sorted 
GFP-expressing NPC populations (mean ± SEM, n = 4 independent experiments). Populations 
were compared using Student’s t test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. E) IF of 
cortical/forebrain-, midbrain-, and hindbrain/spinal-cord-associated markers in neuronal cultures 
differentiated from sorted GFP-expressing NPC populations (scale bar, 100 µm). L, GFPLOW; M, 
GFPMID; H, GFPHIGH. 
2.3.3. Exogenous modulation of WNT signaling influences NPC positional identity 
and reduces heterogeneity in neuronal differentiation 
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The above analysis demonstrates that endogenous WNT signaling activity correlates with 
A/P regional identity of NPCs. To determine the extent to which WNT signaling is instructive in 
conferring regional bias, we used several methods to perturb WNT signaling during NPC 
generation. Specifically, we differentiated four independent hPSC lines (H9, HUES9, HES3, and 
RiPSC; (Warren et al., 2010)) to NPCs while activating or inhibiting WNT signaling with CHIR 
98104 (CHIR, a potent inhibitor of GSK-3β) and IWP2, respectively (Figure 2.4A). Activation of 
WNT signaling with CHIR treatment led to an increase in embryoid body (EB) size, whereas 
inhibition of endogenous WNT signaling through IWP2 treatment resulted in a decrease in EB 
size (Figures A.5A and A.5B), consistent with the known role of canonical WNT signaling in 
promoting proliferation in hESC-derived neurospheres (Davidson et al., 2007). CHIR-treated and 
IWP2-treated NPCs expressed levels of the pan-neural markers SOX1, SOX2, and NESTIN 
similar to those observed for untreated NPCs (Figures A.5C–A.5E). 
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Figure 2.4 Exogenous Manipulation of WNT Signaling Reduces Heterogeneity in NPC Cultures 
A) Outline of the experimental protocol. CHIR or IWP2 was added during day 2 of neural 
differentiation. CHIR- and IWP2-treated and untreated NPCs were expanded for four passages 
prior to differentiation to neurons. B and C) Gene-expression analysis of (B) FOXG1 and (C) 
HOXB4 in NPC cultures derived from H9 hPSCs in the presence of varying levels of CHIR and 
IWP2. D) /P gene expression in 500 nM CHIR- and 1,000 nM IWP2-treated and untreated NPC 
cultures derived from H9, HUES9, HES3, and RiPSC hPSCs (mean ± SEM, n = 3 independent 
experiments). Populations were compared with untreated (N) cells using Student’s t test. ∗p < 
0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. E) IF of A/P-related markers in 500 nM CHIR- and 1,000 nM 
IWP2-treated and untreated NPC cultures (scale bar, 100 µm). F and G) FC of (F) FORSE-1 and 
(G) PAX6 in 500 nM CHIR- and 1,000 nM IWP2-treated and untreated NPC cultures. Isotype 
controls used are listed in Table S5. N, none; C, CHIR 98014; I, IWP2. 
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Although there was no effect of WNT signal perturbations on the formation of SOX1+, 
SOX2+, and NESTIN+ NPCs, CHIR or IWP2 treatment influenced the A/P expression profile of 
NPCs. Expression of the anterior marker FOXG1 decreased in a dose-dependent manner with 
CHIR treatment, but increased with IWP2 treatment (Figure 2.4B). Conversely, the levels of the 
posterior marker HOXB4 increased in a concentration-dependent manner with CHIR treatment, 
but decreased with IWP2 treatment (Figure 2.4C). The expression of A/P markers was also 
influenced by CHIR and IWP2 treatment across all hPSC lines tested (Figures 2.4D–2.4G). 
Specifically, expression of the anterior markers FOXG1, FORSE-1, SIX3, DLX2, OTX2, and 
PAX6 was higher in IWP2-treated cells, whereas expression of the posterior markers IRX3, 
HOXA2, and HOXB4 was higher in CHIR-treated cells. To eliminate the possibility that the 
posteriorizing effect of CHIR was not due to the activation of other signaling pathways that act 
through GSK3 (Jope & Johnson, 2004), we also generated NPCs in the presence of WNT3a (K. 
H. Willert, 2008). Similar to the effect of CHIR on A/P gene expression of NPCs, addition of 
WNT3a during NPC formation led to an increase in expression of the posterior genes LMX1A, 
EN1, IRX3, and HOXB4, and a decrease in expression of the anterior genes FOXG1, SIX3, 
DLX2, and OTX2 (Figure A.5F). These data demonstrate that exogenous activation or inhibition 
of canonical WNT signaling can be used to control the positional patterning of NPCs in 
differentiating hPSCs. Additionally, the observation that inhibition of endogenous WNT signaling 
with IWP2 during NPC generation reduced the expression of genes associated with posterior 
identity suggests that endogenous WNT signaling specifies a posterior identity, consistent with its 
known function in CNS development. 
To examine whether patterning of NPCs imposed by exogenous WNT manipulation was 
stable, we cultured CHIR- and IWP2-treated NPCs in the absence of these exogenous signals for 
ten passages (>50 days) (Figures A.6A and A.6B). After ten passages, the expression level of the 
forebrain marker FOXG1 remained unchanged in NPCs that were generated in the presence of 
IWP2 (Figure A.6C). Along similar lines, the expression level of the hindbrain marker HOXB4 
remained constant over ten passages of the NPCs that were generated in the presence of CHIR 
(Figure A.6D). Therefore, continued WNT pathway modulation during prolonged culture was not 
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required to maintain the regional identity of NPCs. Furthermore, we examined the ability of NPCs 
to alter their positional identity after NPC formation. To test this, we treated regionally specified 
NPCs with CHIR or IWP2 for ten passages after NPC formation (Figures A.6A and A.6B). 
Addition of CHIR to anterior-specified NPCs (i.e., NPCs formed in the presence of IWP2) had no 
effect on FOXG1 or HOXB4 expression (Figures A.6C and A.6D). Likewise, IWP2 treatment of 
posterior-patterned NPCs (i.e., NPCs formed in the presence of CHIR) did not change their 
regional identity (Figures A.6C and A.6D). Collectively, these data suggest that the effect of 
exogenous WNT signaling on NPC patterning is imparted early during their generation and NPCs 
are unable to interconvert between positional identities during subsequent expansion. 
We subsequently investigated whether NPCs generated with IWP2 or CHIR treatment 
retained their regional phenotype upon differentiation to neurons. IWP2- and CHIR-treated NPCs 
were expanded for four passages and then subjected to the neuronal differentiation protocol. IF 
(Figure 2.5A) and gene expression (Figure A.5G) revealed that IWP2- and CHIR-treated NPCs 
generated similar numbers of B3T+ neurons compared with untreated NPCs. However, neurons 
generated from IWP2-treated NPCs expressed higher levels of the forebrain- and cortical-related 
neuronal markers FOXG1, TBR1, SATB2, CTIP2, EMX1, CUX1, and OTX2 compared with 
neurons generated from CHIR-treated or -untreated NPCs (Figures 2.5B and 2.5C). On the other 
hand, neurons generated from CHIR-treated NPCs expressed higher levels of the hindbrain- and 
spinal-cord-specific markers HOXA2, HOXB4, HOXB6, and MNX1 (Figures 2.5B and 2.5C). 
Together, our results indicate that NPCs retain their regional identity over multiple passages and 
manifest that identity in differentiated neuron cultures. 
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Figure 2.5 Analysis of Neurons Derived from CHIR- and IWP2-Treated and Untreated NPC 
Cultures A) IF of mature neuronal markers B3T in neuronal cultures differentiated from 500 nM 
CHIR- and 1,000 nM IWP2-treated and untreated NPC cultures derived from H9 hPSCs (scale 
bar, 100 µm). B) IF of cortical-, forebrain-, midbrain-, hindbrain-, and spinal-cord-related neuronal 
genes in neurons differentiated from 500 nM CHIR- and 1,000 nM IWP2-treated and untreated 
NPC cultures derived from H9 hPSCs (scale bar, 100 µm). C) Expression of cortical-, forebrain-, 
midbrain-, hindbrain-, and spinal-cord-related neuronal genes in neurons differentiated from 500 
nM CHIR- and 1,000 nM IWP2-treated and untreated NPC cultures derived from H9, HUES9, 
HES3, and RiPSC hPSCs (mean ± SEM, n = 4 independent experiments). Populations were 
compared with neurons differentiated from untreated (N) NPCs using Student’s t test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. 
Although we were able to generate NPC and neuron cultures with distinct anterior and 
posterior identities, we did not observe cell populations expressing markers associated with a 
midbrain phenotype. We speculated that this notable absence of midbrain cell types may have 
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been the consequence of endogenous WNT signaling activities that influence the extent to which 
exogenous WNT signaling imparts A/P identities. To eliminate the contribution of any 
endogenous WNT signaling during NPC generation and fine-tune the level of WNT signaling 
activity, we treated differentiating cultures (hPSCs to NPCs) with IWP2 simultaneously with 
increasing concentrations of CHIR. Analysis of the gene-expression profile of NPCs derived at 
various concentrations of CHIR revealed that we could specify the A/P positional identity of NPCs 
by precisely controlling the level of exogenous WNT signaling (Figures 2.6A–2.6C). In all hPSC 
lines tested, induction of NPCs with a midbrain phenotype occurred at a narrow CHIR 
concentration range, with the precise CHIR range varying slightly between hPSC lines. CHIR 
concentrations significantly lower or higher than these optima led to the production of NPCs with 
an anterior/forebrain or hindbrain/spinal-cord phenotype, respectively. 
	
Figure 2.6 Specification of the Midbrain Neural Phenotype through Precise Exogenous 
Manipulation of WNT Signaling A and B) Gene-expression analysis of A/P-related genes in NPCs 
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generated from (A) H9 (mean, n = 3 technical replicates) and (B) HUES9, HES3, and RiPSC 
(mean, n = 3 independent experiments) hPSCs in the presence of 1,000 nM IWP2 and various 
concentrations of CHIR. The data are displayed in a heatmap where black corresponds to 
minimum expression levels and red corresponds to maximum levels. For each gene analyzed, 
the expression levels were normalized to the sample with the highest expression level. C) IF of 
LMX1A expression in NPCs generated from H9 hPSCs in the in the presence of 1,000 nM IWP2 
and various concentrations of CHIR (scale bar, 100 µm). D) Gene-expression analysis of 
midbrain-related genes in neuronal cultures differentiated from NPCs treated with various CHIR 
concentrations (mean; H9, n = 3 independent experiments; HUES9, HES3, RiPSC, n = 4 
independent experiments). E) IF of NURR1 expression in NPCs generated from H9 hPSCs in the 
in the presence of 1,000 nM IWP2 and various concentrations of CHIR (scale bar, 100 µm). 
We differentiated these NPCs of specific positional fate to neurons. Expression of the 
midbrain neuronal-related markers GATA2, GATA3, LMX1A, LMX1B, NURR1, PITX3, and TH 
peaked at a CHIR concentration of 10 nM for NPCs generated from H9 or RiPSC hPSCs, and a 
CHIR concentration of 50 nM for NPCs generated from HUES9 or HES3 hPSCs (Figures 2.6D 
and 2.6E). Together, these data indicate that by selecting the precise level of extrinsic WNT 
signaling in the context of suppressed endogenous WNT signaling, we could generate hPSC-
derived NPCs and neurons with midbrain characteristics. 
2.4. Conclusion 
hPSCs and their derivative NPCs share the ability to self-renew indefinitely while retaining 
the potential to differentiate into mature cell types, although the potential of NPCs is restricted to 
cells of the CNS, including neurons, astrocytes, and oligodendrocytes. Our study demonstrates 
that NPCs are additionally restricted by their positional identity. As in development of the CNS, 
where establishment of the A/P axis early during neural tube formation confers a specific 
positional identity on naive neuroepithelial cells, NPCs acquire similar positional information from 
their microenvironment. Importantly, despite their apparent homogeneous appearance and lack of 
a clear 3D architecture, NPCs in cell culture acquire and stably maintain this A/P positional 
identity. In contrast to this stable identity of NPCs, where individual and heterogeneous states 
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coexist and do not interconvert, ESCs exist in a metastable state in which individual cells exhibit 
oscillatory expression of transcription factors (Cahan & Daley, 2013; Canham, Sharov, Ko, & 
Brickman, 2010; de Souza, 2012; Galvin-Burgess, Travis, Pierson, & Vivian, 2013; Narsinh et al., 
2011; Stewart et al., 2006),  correlating with a bias to either self-renew or differentiate. 
Importantly, we show that NPC positional identity and specific neuronal differentiation potential 
are retained over prolonged expansion (>50 days) in culture. 
The WNT signaling pathway is a primary determinant in assigning an A/P positional identity 
to NPCs. This instructional cue is imparted early during NPC generation and once this identity is 
established, it is stable and cannot be altered through exogenous manipulation of the WNT 
pathway. Using a WNT reporter line, we show that endogenous WNT signaling is highly variable 
among individual cells as they acquire a NPC phenotype, with cells of posterior identity 
expressing WNT reporter activity. In addition to expressing markers of posteriorly fated NPCs, 
most notably genes of the HOX gene cluster, these cells also express multiple WNT ligands. In 
contrast, NPCs with anterior identity, as detected by a lack of WNT reporter activity, express 
multiple WNT antagonists. These differences in expression of WNT agonist and antagonist 
resemble those observed in the developing neural tube in vivo, with posterior tissues expressing 
WNT proteins and anterior tissues expressing WNT antagonists such as DKK1 and FRZB 
(Hashimoto et al., 2000; Leyns et al., 1997). 
These opposing WNT signals generate an endogenous gradient of WNT activity, which 
divides the embryonic neural tube along the A/P axis into distinct progenitor domains, each of 
which gives rise to specific regionalized neurons (Ciani & Salinas, 2005; Kiecker & Niehrs, 2001; 
Nordström, Jessell, & Edlund, 2002). These progenitor domains have regionally specific gene-
expression profiles and differentiation predispositions despite similar levels of expression of the 
pan-neural markers SOX1 and SOX2 (Pevny et al., 1998; Wood & Episkopou, 1999; Zappone et 
al., 2000). Here, we showed that NPCs exhibited a broad range of endogenous WNT activity that 
conferred specific regionalized fates despite comparable expression levels of SOX1 and SOX2, 
perhaps mimicking the same developmental events that are seen during early in vivo neural tube 
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development. Therefore, the local WNT microenvironment tightly regulates the WNT activity 
status and hence the positional identity of NPCs. 
A somewhat unexpected implication of these gene-expression patterns is that WNT 
signaling appears to be acting cell autonomously, with WNT signaling activity restricted to those 
cells expressing WNT genes. Although WNT signaling activity is present in a graded fashion in 
these NPC cultures, WNT proteins are acting in an autocrine rather than paracrine manner. 
Furthermore, expression of WNT antagonists may mute the response in cells near or adjacent to 
WNT secreting cells. A more careful analysis of this cell-based system will likely yield important 
mechanistic insights into the dynamic nature of WNT signaling during development. 
This restricted WNT signaling activity observed in NPC cultures is consistent with the 
notion that WNT proteins act locally (Habib et al., 2013) and exhibit minimal, if any, extracellular 
diffusion. A recent study demonstrated that flies expressing an engineered membrane-tethered 
Wingless (a fly WNT protein) are viable and normally patterned, suggesting that the spread of 
Wingless is dispensable for patterning and growth (Alexandre et al., 2013). Similarly, in our cell-
based system, WNT proteins act locally and do not signal to distant cells. In addition, expression 
of WNT antagonists in the WNT− populations may act to block paracrine WNT signaling activity. 
This local WNT activity is not the result of the physical separation of distinct WNT expressing 
domains, since this localized activity is retained in a mixed and seemingly homogeneous cell 
culture system. 
While endogenous WNT signaling activity is a major source of heterogeneity among 
individual NPCs, exogenous manipulation of this signaling pathway can be exploited to impart 
specific positional identities to NPCs during their generation from hPSCs, thereby reducing 
cellular heterogeneity. Activation of WNT signaling with purified WNT3a protein or a GSK-3β 
inhibitor (CHIR98014) led to the generation of NPCs with a hindbrain/spinal cord identity, 
whereas inhibition of WNT signaling with a PORCN inhibitor (IWP2) to block endogenous WNT 
protein processing led to the generation of NPCs with a forebrain phenotype. As shown in this 
and other studies (X.-J. Li et al., 2009; Pankratz et al., 2007), in the absence of any WNT 
pathway manipulations, NPCs generated form hPSCs are generally biased toward an anterior 
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fate, suggesting that endogenous WNT signaling in these culture systems is relatively low and 
insufficient to promote posterior fates. Consequently, ectopic activation of WNT signaling 
produces a prominent shift from an anterior to a posterior fate. In contrast, in the absence of WNT 
signaling (through IWP2 addition), the relative increase of anterior-related markers, though 
statistically significant, is less pronounced. 
Although exogenous manipulation of WNT signaling can be used to reduce NPC 
heterogeneity, the window during which this manipulation is effective is limited. Specifically, we 
find that WNT signaling imparts positional identity early during NPC generation, likely during the 
rosette stage, in which the cell population most closely resembles the early developing neural 
tube. Once an NPC culture is established and propagated over multiple passages, A/P positional 
identity is stable and recalcitrant to exogenous manipulations of WNT signaling. Therefore, the 
identity, concentration, and timing of factors (e.g., WNTs) added during NPC generation are 
critical to produce homogeneous cultures. 
Although WNT signaling plays a prominent role in A/P patterning of the neural tube, few 
studies have extensively examined the influence of WNT on the A/P positional identity of hPSC-
derived NPCs and neurons. To date, most studies have relied on FGF8 (Y. Yan et al., 2005; D. 
Yang, Zhang, Oldenburg, Ayala, & Zhang, 2008) or retinoic acid (RA) (Dimos et al., 2008; Hu & 
Zhang, 2009; X.-J. Li et al., 2005, 2008; Singh Roy et al., 2005) to generate posterior neural 
populations, such as midbrain dopaminergic and spinal cord motor neurons, respectively, from 
hPSCs. Similar to the approach we used in our study, two groups recently used a specific 
concentration of the GSK3β inhibitor CHIR99021 (an analog to the GSK3β inhibitor used in this 
study) to generate midbrain dopaminergic neurons from hPSCs (Kirkeby, Grealish, et al., 2012a; 
Kriks et al., 2011). However, the ability of this compound to generate stable NPC populations 
from different areas of A/P axis was not extensively studied. We demonstrated that through 
precise chemical modulation of WNT signaling, we could control the A/P positional identity of 
hPSC-derived NPCs. Moreover, we demonstrated that these NPCs retained their positional 
specificity as they were differentiated to neurons in vitro. It should also be noted that previous 
studies (Hu & Zhang, 2009; Y. Yan et al., 2005) have relied on the activation of SHH signaling in 
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order to generate ventral neurons, such as mDA and motor neurons. In this study, we 
demonstrated that we were able to generate these ventral neuronal subtypes without exogenous 
modulation of SHH signaling. This suggests the possibility that endogenous SHH signaling may 
regulate the dorsal-ventral (D/V) identity of hPSC-derived NPCs and neurons analogously to the 
manner in which endogenous WNT signaling regulates their A/P identity. Nonetheless, our study 
serves as proof-of-principle that modulation of developmental signaling pathways, such as WNT 
and SHH, can be exploited to refine the A/P and D/V identity of NPCs and neurons. 
Our findings regarding the positional restriction of NPCs have important implications for the 
study and application of these cells. Several studies have described the transplantation of hPSC-
derived NPCs into animal models of Parkinson’s disease, Huntington’s disease, amyotrophic 
lateral sclerosis, and spinal cord injury (S. U. Kim, Lee, & Kim, 2013; Lindvall & Kokaia, 2010). 
However, few of these studies have described a successful long-term reduction in the symptoms 
associated with these disorders (S. U. Kim et al., 2013; Lindvall & Kokaia, 2010). Interestingly, 
several of these studies relied on NPCs generated by dual SMAD inhibition, which results in 
NPCs of an anterior telencephalic identity (Chambers et al., 2009), which may explain the lack of 
symptomatic improvement in animal models of disorders associated with the midbrain, hindbrain, 
and spinal cord. We speculate that future animal transplantation studies that utilize regionally 
specific and stably expandable NPCs, such as those generated in this study, will result in a 
significant improvement in the cognitive and motor deficits associated with these neurological 
disorders. 
In summary, we determined that endogenous WNT signaling influences the heterogeneity, 
regional characteristics, and differential potential of hPSC-derived NPCs. In addition, we showed 
that precise exogenous modulation of WNT signaling during neural differentiation of hPSCs 
results in a homogeneous NPC population with a specific positional identity. Importantly, 
manipulation of endogenous and exogenous WNT signaling will allow for the development of 
defined methods for generating transplantable hPSC-derived NPCs for specific regions of the 
entire A/P axis of the neural tube. Furthermore, this study suggests that modulation of other 
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refine the positional identity of NPCs and neurons. In the future, these regionally specific NPCs 
will greatly enhance the translational potential of hPSCs for neural-related therapies. 
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CHAPTER 3 
TRANSCRIPTIONAL REGULATION OF NEURAL FATE THROUGH A MULTI-STATE MODEL 
OF WNT/B-CATENIN SIGNALING 
3.1. Introduction 
Multiple coordinating signaling pathways are required for proper induction and patterning of 
the vertebrate neural tube. This process is hypothesized to follow a two-step process, neural 
induction or “activation” which entails acquisition of an anterior fate followed by progressive 
caudalization with a “transforming” factor (Nieuwkoop, 1952; Nieuwkoop & Nigtevecht, 1954).  
Neural induction is well known to rely on the action of the Spemann organizer, discovered 
through groundbreaking transplantation experiments, which emits signals to antagonize BMP 
signaling, this serves as the “activation” step (Hemmati-Brivanlou et al., 1994; SASAI, 1994; 
Sasai et al., 1995; Smith & Harland, 1992). The transformative factor remained elusive for many 
years and was hypothesized to be due to the action of morphogens such as WNTs, FGFs, or RA. 
WNTs compose a large family of evolutionarily conserved lipid-modified, secreted 
glycoproteins (Clevers & Nusse, 2012). WNT signaling plays a diverse set of roles and influences 
many cell processes fundamentally related to symmetry breaking, these processes can broadly 
be divided into controlling ‘cell fate’ (canonical) or ‘cell polarity’ (non-canonical) (Loh, van 
Amerongen, et al., 2016). Canonical WNT signaling hereafter referred to as WNT/β-catenin 
signaling, is better studied than non-canonical WNT signaling and focuses on the fate of β-
catenin. In the absence of a WNT ligand, a complex of proteins known as the destruction complex 
constitutively degrades β-catenin (Jennifer L Stamos & Weis, 2013). WNT bound to its cognate 
frizzled (Fz) receptor triggers formation of disheveled (DVL) dependent LRP6 signalosomes at 
the plasma membrane, which subsequently recruits Axin, thus dissociating the destruction 
complex and allowing accumulation of β-catenin in the cytoplasm (Bilic et al., 2007)  β-catenin 
then translocates to the nucleus where is recruited to chromatin via transcription factors (TFs), 
most well characterized are the TCF/LEF TFs, to bind chromatin and activate WNT target gene 
expression (Cadigan, 2012) As a function of its diverse cellular roles, aberrant WNT signaling 
	 	
52 
 
results in a variety of severe developmental disorders and multiple forms of cancer (Clevers & 
Nusse, 2012; Logan & Nusse, 2004). 
WNT/β-catenin plays an essential role as a morphogen in patterning the anteroposterior axis 
in the developing neural tube (Kiecker & Niehrs, 2001; McGrew et al., 1995; Nordström et al., 
2002) A progressive gradient establishes more caudal neural fates. Local inhibition of WNT 
signaling in the caudal region antagonizes WNT signaling in the prospective telencephalon to 
ensure proper development (Glinka, Wu, Onichtchouk, Blumenstock, & Niehrs, 1997). When 
WNT inhibition is prevented such as through mutation in TCF3 (C. H. Kim et al., 2000) or 
inhibition of DKK1/SFRPs, the telencephalon fails to develop, leading to expansion of caudal 
fates. (Mukhopadhyay et al., 2001) Conversely, WNT3a mutant mice or introduction of a 
dominant negative xWNT8 result in severe abnormalities in hindbrain and spinal cord patterning 
(Erter, Wilm, Basler, Wright, & Solnica-Krezel, 2001; Lekven, Thorpe, Waxman, & Moon, 2001; 
Takada et al., 1994). Additionally WNTs are thought to act in concert with other morphogens such 
as FGFs and RA to ensure proper patterning of the developing neural tube (Gavalas & Krumlauf, 
2000; Hikasa & Sokol, 2013; Holowacz & Sokol, 1999; Kudoh, Wilson, & Dawid, 2002; McGrew et 
al., 1997; Partanen, 2007). Multiple labs, including ours have leveraged this information to 
generate regionally patterned hNPCs and organoids from human pluripotent stem cells (hPCSs) 
for disease modeling and cell transplantation (Di Lullo & Kriegstein, 2017; Kirkeby et al., 2012; 
Moya, Cutts, Gaasterland, Willert, & Brafman, 2014). 
Although many studies have been performed to characterize the complex gene regulatory 
networks responsible for patterning and WNT/ β-catenin has well characterized activity in neural 
patterning the transcriptional mechanisms due to WNT/β-catenin signaling in the developing 
neural tube are not well understood. Here we utilize a protocol previously established in the lab to 
generate patterned hNPCs in conjunction with β-catenin chromatin immunoprecipitation 
sequencing (CHIP-seq) to understand the transcriptional events of β-catenin, which lead to 
proper neural patterning (Cutts, Brookhouser, & Brafman, 2016; Moya et al., 2014). We find that 
different levels of WNT signaling lead to mainly unique β-catenin binding. Additionally, 
identification of enhancers in patterned hNPCs revealed that β-catenin binds many of these cis-
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regulatory elements, consistent with a view of β-catenin binding to promote enhancer-promoter 
looping to regulate transcription. (Estarás et al., 2015; Yochum, Sherrick, Macpartlin, & 
Goodman, 2010) This study provides mechanistic insight into how graded levels of β-catenin 
regulate cell fate in neural patterning in the developing neural tube. 
3.2. Experimental Methods 
3.2.1. Human embryonic stem cell culture (hESC) 
hPSCs were passaged in feeder free conditions in Essential 8 medium (Life Technologies) 
on Matrigel (BD Biosciences). Cells were routinely passaged with Accutase (Millipore) and 
replated at a density of 4.25 x 104 /cm2 every 3-4 days. 
3.2.2. Human neural progenitor cell (hNPC) generation 
Human pluripotent stem cell (hPSC)-derived neural progenitor cells (hNPCs) were 
generated as previously described. (Cutts et al., 2016) Briefly hESCs were dissociated to single 
cell using Accutase (Stem Cell Technologies) for 5 min and resuspended in neural induction 
media (1% N2/1% B27 without vitamin A/DMEM:F12) supplemented with 5 uM Y-26732 (Santa 
Cruz Biotechnology), 50 ng/ml recombinant human noggin (R&D Systems), and 0.5 µm 
Dorsomorphin (Santa Cruz Biotechnology). Next, 2*106 cells were pipetted to each well of a 6-
well ultra low-attachment plate (Greiner Bio-One) and placed on an orbital shaker at 95 rpm in a 
37 oC/5% CO2 tissue culture incubator. The next day, cells formed spherical clusters (embryoid 
bodies (EBs)) and a half media change was performed. After 2 days in culture IWP2 (Sigma-
Aldrich) or CHIR98014 (Sigma-Aldrich) were added. Media changes were subsequently 
performed every day. 
3.2.3. Quantitative PCR (qPCR) 
RNA was isolated from cells using the NuceloSpin® RNA kit (Macherey Nagel). Reverse 
transcription was performed with iScript RT Supermix (Bio-Rad). Quantitative PCR was carried 
out using SYBR green dye on a CFX384 Touch™ Real-Time PCR Detection System. QPCR 
experiments run with SYBR green dye were carried out using iTaq Universal SYBR Green 
Supermix (Bio-Rad). For qPCR experiments run with SYBR green dye, a 2 min gradient to 95 oC 
followed by 40 cycles at 95 oC for 5 s and 60 oC for 30 s was used. The list of primer sequences 
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used in provided in Supplementary Table 1. Gene expression was normalized to 18S rRNA 
levels. Delta Ct values were calculated as Cttarget – Ct18s. Relative fold changes in gene 
expression were calculated using the 2-ΔΔCt method. Data are presented as the average of the 
biological replicates ± standard error of the mean (S.E.M.).  
3.2.4. Generation of CTNNB1-3xFLAG hESC line 
Cas9 protein was purchased from PNA Bio Inc (Cat.No. CP01). The full length of gRNA 
carrying 20 mer target sequence of the human beta-catenin gene (ttacctaaaggatgatttac) was In 
Vitro synthesized by using HiScribe T7 High Yield RNA Synthesis Kit (NEB Cat.No. E2040S).  
The donor single strand oligo(ssODN) was synthesized by IDT company(www.idtdna.com). The 
sequence of the donor ssODN is: 
CtcatggatgggctgcctccaggtgacagcaatcagctggcctggtttgatactgacctgGACTACAAGGACCACGACGG
CGATTATAAGGATCACGATATCGACTACAAAGACGACGATGACAAGTGAatcatcctttaggtaagaag
ttttaaaaagccagtttgggtaaaatacttttactctgcc 
hESCs were individualized by Accutase treatment, washed once with 1×PBS and spun 
down at 300 g for 3 minutes, 0.2 million of cells were resuspended in 10ul of R buffer (Invitrogen). 
cell suspension was added into a 1.5ml Eppendorf tube containing 1µg of gRNA/Cas9 RNP 
complex and 1µl of 10uM donor SSODN. The mixture of Cas9 protein, gRNA, donor plasmids 
and cells were then subjected to electroporation using Neon Transfection System (Life 
technologies) by following the Manufacture’s instruction. The survived cells were maintained in 
mTeSR/Geltrex condition for 10 days. Then, 32 colonies were randomly picked up for PCR 
screening and DNA sequencing to identify the colony with correct homologous recombination. 
The positive colonies confirmed by DNA sequencing were further single-cell subcultured and 
expanded.  
3.2.5. Chromatin Immunoprecipitation 
Chromatin immunoprecipitation was performed as in Estaras et. al with some modifications. 
(Estarás, Benner, & Jones, 2015). 2 x 107 cells were double crosslinked with 0.2 mM di (N-
succinimidyl) glutarate (DSG, Sigma, 80424) for 45 min followed by 1% formaldehyde 
(ThermFisher Scientific, 28906) for 15 min. Cell were lysed with cell lysis buffer (10 mM Tris pH 
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8.0, 10 mM NaCL, 0.2% NP40, protease inhibitors) for ice on 10 min, spun down at 2500 RPM 
and lysed in nuclei lysis buffer (50 mM Tris 8.1, 2 mM EDTA, 1% SDS, protease inhibitors) for 
10 min on ice. Lysate was sonicated in IP dilution buffer (20 mM Tris pH 8.1, 2 mM EDTA, 150 
mM NaCal, 1% Triton X-100, 0.1% SDS, protease inhibitors) in a Qsonica Q700 bath sonicator 
at amplitude 60, 15 seconds ON, 45 seconds OFF for a process time of 3:45, repeated 8 times. 
Subsequently sonicated lysates were spun down at max RPM for 10 min  precleared with 
magnetic beads (ThermoFisher, 88802) for 1 hour, and subjected to 5 ug α-GFP (Abcam, 
ab290) overnight. Following overnight incubation with anitbody, a one hour incubation with A/G 
magnetic beads was performed followed by subsequent washes with low salt wash buffer (0.1% 
SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-Hcl pH 8.0, 150 mM NaCl), high salt wash 
buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris, pH 8.0, 500 mM NaCl), LiCl wash 
buffer (0.25M LiCL, 1% NP40, 1% deoxycholate, 1 mM EDTA, 20 mM Tris pH 8.0), and 2x TE 
washes. DNA was then eluted in fresh elution buffer and uncrosslinked at 65 C for 4 hours with 
NaCL treatment and treated overnight at 50 C with proteinase K.  
3.2.6. RNA-seq analysis 
All RNA sequencing was performed at BGI Americas Corporation. Libraries for RNA-Seq 
were prepared with KAPA Stranded RNA-Seq Kit. The workflow consists of mRNA enrichment, 
cDNA generation, and end repair to generate blunt ends, A-tailing, adapter ligation, and PCR 
amplification. Different adapters were used for multiplexing samples in one lane. Sequencing was 
performed on a BGISEQ-500 for a single end 50 bp run. Reads were filtered to remove reads 
which contained adapter sequences, high content of unknown bases, and low quality reads. 
Reads were aligned to the hg19 reference genome using STAR v2.5.2b (Dobin et al., 2013). 
Differential analysis was performed using edgeR with a threshold of FDR < 0.05 and FC > 2 
(Robinson, McCarthy, & Smyth, 2010). Heatmaps were generated using Heatmapper (Babicki et 
al., 2016). Gene ontology analysis was performed using DAVID (D. W. Huang, Sherman, & 
Lempicki, 2009).  
3.2.7. ChIP-seq analysis 
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ChIP DNA was sequenced in an Illumina Nextseq500. Reads were aligned to the Human 
hg19 genome assembly using BWA v0.7.10 (H. Li, 2013). Peak finding, motif finding, and peak 
annotation were performed using HOMER (Heinz et al., 2010). Binding peaks for β-catenin ChIP-
seq were identified using ‘findPeaks’ command in HOMER with default settings of ‘-style factor.’ 
Genome browser read density files were created using deepTools (Ramírez et al., 2016) and 
visualized using IGV (Thorvaldsdóttir, Robinson, & Mesirov, 2013).  
Enhancer identification was performed using RFECS based on the use of H3K4me3, H3K27me3, 
and H3K4me1 (Rajagopal et al., 2013). Identified enhancers were merged if within 1600 bp of 
each other using bedtools (A. R. Quinlan & Hall, 2010). Identified enhancers were annotated 
using Genomic Regions Enrichment of Annotations Tool (GREAT) (McLean et al., 2010). 
3.3. Results and Discussion 
3.3.1. Characterization of in vitro neural differentiation 
We utilized our previously developed protocol to generate regionalized hNPCs from 
hPSCs using BMP inhibition in conjunction with a gradient of WNT signaling established using the 
WNT agonist CHIR98014 (Cutts et al., 2016; Moya et al., 2014) (Figure 3.1A). We first performed 
RNA-seq on embryonic stem cell (ES), neuroectodermal cells (NE), anterior- (A), midbrain- (M), 
and posterior- (P) patterned hNPCs to generate transcriptional signatures to further interrogate. 
We identified differentially expressed genes (FC > 2 and FDR < 0.05) that transcriptionally 
defined each cell type (Figure 3.1B). When we examined these transcriptional signatures we 
observed robust expression of cell type specific genes. ESCs highly expressed the transcription 
factors NANOG and POU5F1, which are critical components of the core transcriptional regulatory 
circuit governing pluripotency (Boyer et al., 2005). FOXB2 and PHOXA2 are markers of early 
neuroectodermal cells and are expressed highly in NE cells (Brunet & Pattyn, 2002; Pohl, 
Knöchel, Dillinger, & Knöchel, 2002). Well established markers of telencephalon development, 
FOXG1 and SIX3 are enriched in A- patterned hNPCs (Oliver et al., 1995; W. Tao & Lai, 1992). 
Genes uniquely upregulated in M- patterned hNPCs included essential genes for mesencephalic 
and dopaminergic neuron differentiation, LMX1B, EN1, and WNT1 (Chao Guo et al., 2007; 
Simon, Saueressig, Wurst, Goulding, & O’Leary, 2001; Smidt et al., 2000). Genes uniquely 
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upregulated in P- patterned hNPCs included important regulators of hindbrain specification and 
canonical WNT targets including HOXC4, HOXD1, FGF8, LEF1, and SP5 (Galceran et al., 1999; 
Sunmonu, Li, Guo, & Li, 2011; Tümpel, Wiedemann, & Krumlauf, 2009). We additionally validated 
expression of several A-, M-, and P- differentially expressed genes identified in transcriptional 
signatures using qPCR futher confirming that these genes are uniquely upregulated in their 
respective cell type (Supplemental Figure B.1A). Finally, correlation analysis between biological 
replicates was high indicating reproducibility of the identified transcriptional signatures of each 
cell type (Figure 3.1C). 
Gene ontology analysis of A-, M-, and P- patterned hNPCs show terms enriched for their 
respective cell type (Figure 3.1D). The gene signature for anterior patterned hNPCs (A) was 
enriched for terms related to forebrain anterior/posterior pattern specification and telencephalon 
regionalization. Anterior/posterior pattern specification and midbrain development terms were 
enriched in midbrain patterned hNPCs. Finally, canonical WNT signaling and hindbrain 
development terms were enriched in genes expressed in posterior patterned hNPCs. Taken 
together these data indicate that the genes identified can confidently be used as transcriptional 
signatures of each cell type.  
	 	
58 
 
	
Figure 3.1 Characterization of an in Vitro Model of Human Neural Patterning A) Schematic of 
differentiation and patterning protocol B) Transcriptional signatures of various cell types identified 
through differential analysis of RNA-seq C) Correlation analysis of RNA-seq biological replicates 
D) Gene ontology over enrichment analysis of A-, M-, and P- patterned hNPCs E) ChIP-seq of 
various cell types of H3K4K9ac, H3K4me3, and H3K27me3 normalized read density in promoters 
of identified transcriptional signatures F) Correlation analysis of RNA-seq, H3K9ac, H3K4me3, 
and H3K27me3 ChIP-seq 
To further characterize our in vitro model of neural patterning we assessed the epigenetic 
state of our identified transcriptional signatures by performing chromatin immunoprecipitation 
sequencing (ChIP-seq) for H3K9ac, H3K4me3, and H3K27me3. H3K9ac is commonly associated 
with gene activation at gene promoters (Brownell et al., 1996; Jin et al., 2011). Bivalent chromatin 
domains possessing both the active mark H3k4me3 and repressive mark H3K27me3 are present 
in ESCs marking developmentally poised genes that are expressed at low levels (Azuara et al., 
2006; Bernstein et al., 2005). However generally H3K4me3 is indicative of active chromatin while 
H3K27me3 marks silent chromatin (Kouzarides, 2007). Consistent with these definitions we found 
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that around promoters, epigenetic marks H3K9ac and H3K4me3 of transcriptional signature 
genes are enriched in their respective cell types while H3K27me3 is depleted (Figure 3.1E). 
Target gene traces for respective cell types ES (NANOG), A- (SIX3), M- (LMX1B), and P- (HOXC 
cluster) patterned hNPCs additionally demonstrate this finding (Supplemental B.1B). Global 
correlation between RNA expression and profiled epigenomic marks are in concordance with this, 
demonstrating positive correlation between RNA and H3K4me3/H3K9ac and negative correlation 
these with H3K27me3 (Figure 3.1F).  
3.3.2. WNT signaling elicits regional transcriptional signatures through β-catenin 
To understand how β-catenin levels lead to distinct transcriptional signatures identified we 
performed neural patterning using incremental amounts of the WNT agonist CHIR98014 followed 
by RNA-seq. Using the transcriptional signatures previously identified we see activation and 
deactivation of M- and P- transcriptional signatures at specific thresholds of 0.05 uM – 2 uM and 
> 3 uM respectively (Figure 3.2A). These findings corroborate previous work that demonstrated 
that WNT/β-catenin signaling acts a morphogen to activate M- and P- cell identities at specific 
thresholds of WNT/β-catenin (Kiecker & Niehrs, 2001). Additionally we observe that the default 
fate of hNPCs in the absence of additional patterning factors is a forebrain identity, supporting the 
two-step hypothesis proposed by Niewkoop and observed in other hPSC neural differentiation 
protocols (Nieuwkoop & Nigtevecht, 1954; Y. Tao & Zhang, 2016). 
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Figure 3.2 WNT Signaling Elicits Regional Transcriptional Signatures through β-catenin A) RNA-
seq of identified A-, M-, and P- transcriptional signatures in a gradient of CHIR B) Expression of 
AXIN2 in ICAT overexpression hESCs (mean ± SEM, n = 3 independent experiments). C) 
Expression of anterior, midbrain, and posterior markers of the neural tube in WT and ICAT 
overexpression hESCs. Populations were compared with neurons differentiated from untreated 
(N) NPCs using Student’s t test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. 
To understand how β-catenin was able to elicit these different transcriptional states we 
aimed to interrupt its ability to affect transcription. β-catenin functions both in adherens junctions 
and as a signaling component of WNT signaling and activates expression of WNT target genes 
through binding additional transcription factors, most commonly TCF/LEF. It is difficult to separate 
its two functions in cellular processes (Tomas Valenta et al., 2012). To overcome this we decided 
to constitutively overexpress the protein inhibitor of β-catenin and TCF (ICAT) which is known to 
bind to the C-terminus of β-catenin and inhibit its ability to interact with transcription factors bound 
to chromatin (Daniels & Weis, 2002; Tago et al., 2000). Thus interfering with β-catenin’s 
transcriptional activity while leaving its ability to bind adherens junctions uninterrupted 
(Supplemental Figure B.2A). We observed stable overexpression of ICAT by qPCR following 
transduction (Supplemental Figure B.2B). Additionally, H1 ICAT overexpression hPSCs show 
impaired expression of the WNT target gene AXIN2 following treatment with CHIR98014, 
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demonstrating that β-catenin’s ability to influence expression of WNT target genes is reduced in 
the presence of ICAT (Figure 3.2B). 
We used our characterized model of neural patterning and differentiated H1 WT and H1 
ICAT hPSCs to A-, M-, and P- patterned hNPCs to delineate the role of WNT/β-catenin mediated 
transcription in cell fate decisions by performing qPCR on target genes identified in our unique 
transcriptional signatures. A- patterned hNPCs most highly expressed telencephalic markers 
FOXG1 and SIX3 (Fig 3.2C). Overexpression of ICAT did not affect FOXG1 expression in A- 
patterned hNPCs while SIX3 was expressed more highly in ICAT with ICAT overexpression. This 
is consistent with previous studies, which have indicated the necessity of WNT inhibition in 
development of the telencephalon (Glinka et al., 1997; Mukhopadhyay et al., 2001). Markers of 
the midbrain EN1 and LMX1B are most highly expressed in M- patterned hNPCs, and are 
significantly downregulated by ICAT overexpression. Our data support previous findings that β-
catenin directly regulates the expression of EN1 (Alves dos Santos & Smidt, 2011). Additionally 
LMX1B is a known regulator of acquisition of midbrain dopaminergic neurons, ICAT 
overexpression inhibits its’ expression consistent with the idea that β-catenin plays important 
roles in specifying midbrain dopaminergic neuron fate (Joksimovic & Awatramani, 2014; C. H. 
Yan, Levesque, Claxton, Johnson, & Ang, 2011). Finally, HOX cluster genes HOXC4 and 
HOXD1, previously identified in our P- transcriptional signature are most highly expressed in P- 
patterned hNPCs in H1 WT hPSCs, while expression is downregulated in ICAT overexpression 
hPSCs. (Figure 3.2C) HOXC4 and HOXD1have previously been shown to be activated in 
response to WNT/β-catenin signaling, these results indicate that by inhibiting β-catenins’ 
transcriptional activity the expression of these signature genes is also inhibited (Janssens, 
Denayer, Deroo, Van Roy, & Vleminckx, 2010; Otero, Fu, Kan, Cuadra, & Kessler, 2004). 
β-catenin activates expression of M- and P- target genes, as evidenced by this data. By 
interfering with β-catenin’s ability to activate transcription through ICAT overexpression we inhibit 
acquisition of M- and P- fates at respective levels of WNT/β-catenin signaling. This suggests that 
β-catenin acts differently at different levels of WNT signaling, to activate specific transcriptional 
signatures. 
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3.3.3. CTNNB1 binding genome wide 
To understand how β-catenin acts to activate expression of M- and P- cell fates during neural 
patterning we performed ChIP-seq in A-, M-, and P- patterned hNPCs. We initially had difficulty 
optimizing a ChIP protocol to capture β-catenin binding events during neural patterning, 
potentially due to its indirect binding of chromatin through transcription factors additional 
transcription factors (Cadigan & Waterman, 2012). To overcome this technical challenge we 
added a 3XFLAG sequence to the C- terminus of β-catenin using a CRISPR mediated targeting, 
we refer to this new hPSC line as CTNNB1-3XFLAG (Supplemental Figure B.3A). We performed 
extensive characterization to ensure proper editing and maintenance of pluripotency by 
sequencing in a selected clone. Sequencing results confirmed successful incorporation of the 
3XFLAG at the C- terminus of β-catenin, and α-FLAG staining shows localization to the 
cytoplasm and nucleus, in line with β-catenins’ known role in adherens junctions and as a 
transcriptional effector of WNT/b-catenin signaling (Supplemental Figure B.3B-B.3C). Cells 
retained a normal karyotype and morphology characteristic of hPSCs, with compact colonies and 
distinct edges (Supplemental Figure B.3D-B.3E). Flow cytometry for TRA1-81 and 
immunofluorescence for NANOG, OCT4, and SOX2 indicate maintenance of pluripotency. Finally 
CTNNB1-3XFLAG cells were subjected to an undirected differentiation. Differentiated cells 
stained positive for SMA, AFP, and B3T indicating that these cells retain the ability to differentiate 
to the 3 germ layers, further demonstrating that these cells retained characteristic pluripotency. 
The CTNNB1-3XFLAG hPSC line serves as a valuable tool to directly map β-catenins’ binding 
during neural patterning, and will also aid the field in future investigations into the transcriptional 
activity of β-catenin in different developmental contexts. 
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Figure 3.3 Characterization of β-catenin  binding genome wide during human neural patterning A) 
Triple venn diagram of Identified β-catenin peaks in A-, M-, and P- patterned hNPCs B) Genome 
browser capture showing β-catenin binding in the promoter of SP5 C) Motif analysis of β-catenin 
peaks identified in M- and P- patterned hNPCs D) Annotation of β-catenin peaks identified in A-, 
M-, and P- patterned hNPCs 
CTNNB1-3XFLAG hPSCs were treated with CHIR98014 for 48 hours and subjected to 
ChIP followed by qPCR using primers against the promoter of the known WNT target gene SP5. 
As expected CHIR treated cells express WNT targets genes AXIN2 and SP5 (Supplemental 
Figure B.4A-B.4B). Additionally CHIR treated cells show significantly higher binding of β-catenin 
in the promoter of SP5 than non-treated cells (Supplemental Figure B.4C). We then differentiated 
this cell line as previously described to A-/M-/P- regional identities and performed α-FLAG ChIP-
seq to identify β-catenin binding genome wide and characterize its activity in A/P neural 
patterning. Global analysis revealed very few peaks in anterior patterned hNPCs (n=22) while 
identifying a much greater number of peaks in midbrain (n=1621) and posterior (n=1274) 
patterned cells (Figure 3.3A). We identified a strong β-catenin peak in the promoter of the 
canonical WNT target gene SP5, and confirmed strong b-catenin binding there by ChIP-qPCR 
(Figure 3.3B and Supplemental Figure B.4D). Interestingly we identified 281 overlapping peaks 
between M- and P- patterned hNPCs and negligible overlap with A- patterned hNPCs, suggesting 
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that the concentration of β-catenin in the nucleus results in unique binding events. To investigate 
this differential binding activity we performed motif analysis on β-catenin peaks identified in M- 
and P- patterned hNPCs. Top motifs identified in β-catenin peaks from M- patterned hNPCs 
include SOX and TCF motifs. SOX transcription factors are closely related to TCF, both being in 
the HMG family (Kormish, Sinner, & Zorn, 2010) SOX transcription factors have been 
demonstrated to act to regulate β-catenin mediated transcription by modulating the WNT 
signaling pathway, inhibiting the ability of β-catenin to elicit transcription in the TOP:flash reporter 
(Zorn et al., 1999) Although in some instances SOX transcription factors, such as SOX2 are 
hypothesized to activate expression of genes such as cyclinD1 (Iguchi et al., 2007; Kormish et al., 
2010). Top motifs identified in β-catenin peaks from P- patterned hNPCs include the TCF motif 
followed by Nanog and Zic3 (Figure 3.3C). β-catenin binding is most well characterized to 
TCF/LEF transcription factors (Cadigan & Waterman, 2012; Schuijers et al., 2014) It is interesting 
that a Zic3 motif is enriched as Zic3 is suggested to have a role in modulating WNT activity, and 
indeed, Zic3 knockdown results in reduction of head size in Xenopus, similar to interruption of 
WNT antagonism in the specification of anterior neural tube (Fujimi, Hatayama, & Aruga, 2012). 
Differential enrichment of motifs suggests a possible mechanism for differential peak binding at 
different concentrations of WNT/β-catenin signaling. Annotation of identified β-catenin peaks 
revealed that only a minority of β-catenin peaks identified in M- and P- patterned hNPCs were 
located in promoters (4 % and 3 % respectively) while the majority of peaks were in intronic and 
intergenic regions (Figure 3.3D). 
Genes annotated to β-catenin peaks identified in M- patterned hNPCs were enriched for 
WNT signaling pathway, anterior/posterior patterning specification, neural tube formation, and 
dopaminergic neuron differentiation (Supplemental Figure B.4C). While genes annotated to β-
catenin peaks identified in P- patterned hNPCs were enriched for canonical WNT signaling, 
anterior posterior patterning, and hindbrain development (Supplemental Figure B.4C). Gene 
ontology analysis of genes annotated to β-catenin peaks reveals differential enrichment of terms 
associated with A/P neural patterning in M- and P- patterned hNPCs.  
3.3.4. Identification of enhancers in neural patterning 
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Since a majority of identified β-catenin peaks were annotated to intronic or intergenic 
regions we hypothesized that β-catenin was interacting with enhancers to influence cell fate 
decisions. Indeed, previous work has indicated that β-catenin interacts with enhancers to 
promoter enhancer-promoter looping of WNT target genes (Estarás et al., 2015; Yochum, 2011; 
Yochum et al., 2010).  
	
Figure 3.4 Identification and Characterization of Enhancers during Human Neural Patterning A) 
Total number of putative enhancers identified during neural progenitor differentiation and 
patterning categorized by H3K27ac and H3K4me1 deposition B) Density of ChIP-seq reads for 
H3K4me1 and H3K27ac relative to the midpoint of putative poised and active enhancers C) Box 
plots of mRNA expression, measured in TPM at linked genes of putative poised and active 
enhancers *** p-value < 2.2e-16 wilcoxon rank sum test. D) Percent of transcriptional signature 
genes marked by an active enhancer ES, embryonic stem cells; NE, neuroectoderm; A, anterior 
hNPCs; M, midbrain hNPCs; P, posterior hNPCs. 
Enhancers are widespread distal regulatory elements that control the spatiotemporal 
expression of genes in development and disease (Kleinjan & van Heyningen, 2005; Sakabe, 
Savic, & Nobrega, 2012; Shlyueva, Stampfel, & Stark, 2014). These genomic loci are bound by 
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tissue specific transcription factors, which subsequently recruit cofactors such as p300 to activate 
gene expression (Merika, Williams, Chen, Collins, & Thanos, 1998). Enhancer identification has 
historically been challenging due to the their long range interactions across the non-coding 
regions of the genome and no known sequence specific code delineating their activity in different 
developmental contexts (Pennacchio, Bickmore, Dean, Nobrega, & Bejerano, 2013) However 
observations that combinatorial presence or absence of histone post translational modifications 
(PTMs) in defined genomic loci mark enhancers, in conjunction with ChIP-seq to map these 
modifications can be used to identify enhancers (Creyghton et al., 2010a; Heintzman et al., 2009, 
2007). We profiled H34me1, H3K27me3, and H3K27ac histone PTMs in our system of human 
A/P patterning using ChIP-seq and identified enhancers using a random forest based algorithm 
for enhancer identification from chromatin state (RFECS) (Rajagopal et al., 2013). Using this 
machine learning based approach to enhancer identification we identified 136,593 unique 
enhancers (Figure 3.4A). This is consistent with the notion that the genome contains hundreds of 
thousands of enhancers that enable precise control of gene expression in different developmental 
contexts (ENCODE Project Consortium, 2012; Shen et al., 2012; Zhu et al., 2013). Previous work 
has demonstrated that the presence or absence of H3K27ac marks active vs. poised enhancers 
(Creyghton et al., 2010b). To that end we classified enhancers as active or poised and found, 
similar to previous work, that most enhancers are in each cell type are poised while only a subset 
are marked as active (Figure 3.4B) (A. Wang et al., 2015). Additionally genes linked to putative 
active vs. poised enhancers are significantly more highly expressed (Figure 4C). Further analysis 
of genes linked to active enhancer via gene ontology revealed that genes linked to active 
enhancers are enriched for regional specific terms (Supplemental Figure B.5A). Motif analysis of 
active enhancers showed that motifs in A-, M-, and P- patterned hNPCs were enriched for SOX 
motifs, consistent with their known role as regulators of neural enhancers (Wegner, 2011). We 
further examined the distribution of active enhancers within our previously identified 
transcriptional signatures and found that genes linked to active enhancers were enriched with 
respect to cell state (Figure 3.4D). These results functionally define active and poised enhancers 
in human A/P patterning and serve well to further interrogate the interaction between β-catenin 
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and enhancers in cell fate decisions. Furthermore this analysis serves as a valuable resource to 
investigate the mechanisms of cell competence during regionalization in neural development.  
3.3.5. β-catenin binding in enhancers falls into multiple classes 
As we hypothesized, the vast majority of β-catenin peaks previously annotated to 
intragenic and intronic regions were re-annotated to identified enhancers (M- 95%, P- 94%) 
(Figure 3.5A). These data support a divergence from the traditional idea of β-catenin controlled 
gene expression where b-catenin binds promoters to activate gene expression (Cadigan, 2012; 
Tomas Valenta et al., 2012). A new model posits that β-catenin instead binds enhancers to act as 
a primer, in concert with other transcription factors, to control expression of target genes 
(Nakamura et al., 2016; Nakamura & Hoppler, 2017; Ramakrishnan & Cadigan, 2017). 
	
Figure 3. 5 Identification and characterization of β-catenin peak classes A) Reannotated β-
catenin ChIP-seq peaks following identification of enhancers B) Model of β-catenin binding in a 
graded manner C) Global classes of β-catenin peaks D) β-catenin in identified transcriptional 
signatures E) Gene ontology over enrichment analysis of genes bound by different classes of β-
catenin peaks F) Representative genome browser captures of class specific genes in gene 
ontology analysis  
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β-catenin peaks were observed to mostly be unique to M- and P- patterned hNPC states, 
but with significant overlap of peaks between the two conditions. We decided to further 
investigate this phenomenon by classifying β-catenin peaks into classes based on overlap or 
uniqueness between M- and P- patterned hNPCs. We defined class I peaks as having an 
overlapping β-catenin peak in both the M- state and P- state. While class II and class III have a β-
catenin peak in only the M- state or P- state respectively. (Figure 5B) We identified 283 class I, 
1346 class II, and 997 class III β-catenin peaks. (Figure 3.5C) When we examined the distribution 
of peaks by class in previously identified transcriptional signatures we observed that the M- 
cluster is enriched for class II β-catenin regulated genes (31/126 ) while the P- cluster is enriched 
for class III β-catenin regulated genes (33/164) (Figure 5D). GO analysis of peaks by class 
indicate that all classes are enriched for general terms related to neural and tube development 
(Figure 3.5E). While class II and III specific affect regionalization of the neural tube and 
acquisition of specific regional identities such as dopaminergic neuron differentiation enriched in 
class II and canonical WNT signaling pathway and hindbrain development were enriched in class 
III.  This suggests that β-catenin regulates neural and tube development generally with class I 
peaks while class II and III peaks regulate genes involved in proper patterning of the developing 
neural tube (Figure 3.5F) 
3.4. Conclusion 
WNT signaling produces unique transcriptional outputs at graded levels of WNT signaling. 
The traditional view of canonical WNT target gene activation fails to capture the observed 
complexity of graded WNT signaling. Several examples of gradients of WNT signaling during 
development demonstrate the necessity of graded activation of WNT targets. Mutations of varying 
severity in APC led to different levels of β-catenin in mouse models of hematopoietic stem cell 
(HSC) development. Luis et. al. demonstrated that different levels of WNT/β-catenin signaling led 
to different HSC function, with low levels of WNT leading to enhanced HSC function, mid levels 
leading to enhanced t-cell differentiation, and high levels impairing HSC function (Tiago C. Luis et 
al., 2011) Additionally it is well known that graded levels of WNT signaling regionalize the 
developing neural tube (Moya et al., 2014; Nordström et al., 2002). Here we used an in vitro 
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model of neural patterning taking advantage of the distinct transcriptional outputs at different 
levels of WNT signaling and profiled the binding of β-catenin to understand how it acts to regulate 
cell fate in a graded manner. 
Studies to date have examined β-catenin binding in the presence or absence of WNT 
activation, which does not take into the account the known gradient transcriptional activity of 
WNT/β-catenin signaling, observed in multiple developmental contexts.  B-catenin chip-seq has 
been performed in colorectal cancer cell lines (Bottomly et al., 2010; Schuijers et al., 2014), HEK 
293T (Doumpas et al., 2019; Schuijers et al., 2014), and murine intestinal crypt cells (Schuijers et 
al., 2014). Additionally β-catenin binding has been examined in multiple hPSC derivatives, 
including primitive streak formation (Funa et al., 2015) and mesendodermal induction (Estarás et 
al., 2015). Finally several β-catenin ChIP-seq studies have been performed in xenopus 
gastrulation (Kjolby & Harland, 2017; Nakamura et al., 2016) and xenopus endoderm 
development (Stevens et al., 2017). Clearly β-catenin acts across multiple developmental 
contexts, consistent with the ability of WNT/β-catenin signaling ability to regulate multiple cell and 
developmental processes. 
In line with previous results we observe that β-catenin binds to enhancers to prime their 
activity (Nakamura et al., 2016). This mechanism may explain how β-catenin is able to serve as a 
transcriptional regulator in a vast number of developmental contexts observed including 
hematopoiesis (Tiago C. Luis et al., 2011), gastrulation (Funa et al., 2015; Nakamura et al., 
2016), and mesendodermal induction (Estarás et al., 2015). Interestingly b-catenin binding events 
are mostly unique in M- and P- patterned hNPCs due entirely to only changes in concentration of 
WNT/b-catenin signaling provided during neural patterning (Figure 3A). Motif analysis suggests 
that differential motif enrichment between M- and P- patterned hNPCs could be due to 
interactions with different transcription factors. At lower concentrations of WNT signaling M- 
hNPCs are specified and SOX motifs are most enriched while at higher concentrations P- 
patterned hNPCs are enriched for TCF/LEF motifs (Figure 3B). SOX motifs have previously been 
shown to act in concert with β-catenin, though their activity in as transcriptional activators has not 
been well characterized (Kormish et al., 2010) We also find that SOX motifs are enriched in active 
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enhancers that we identified (Supplemental Figure 5B) and M- β-catenin peaks are enriched for 
SOX motifs, this suggests interaction between these identified enhancers and identified β-catenin 
peaks. A higher threshold of b-catenin binding could be required for binding to TCF/LEF 
transcription factors that are enriched in b-catenin peaks identified in P- patterned hNPCs. An 
open question remains as to how β-catenin becomes removed from these lower threshold class II 
binding events to turn off genes at this level of WNT/β-catenin signaling.  
Here we characterize β-catenin binding in a graded fashion using our previously 
characterized in vitro model of neural development. Specific levels of WNT activation lead to 
differential cell fate. We find that in line with previous observations, most β-catenin binding lies 
within enhancers to influence cell fate. Additionally we observe β-catenin binding falls into 
different classes depending on the presence or absence of peaks at different levels of WNT 
signaling. A minority of peaks overlap between graded levels of WNT activation while most are 
unique to patterned hNPC populations, corresponding to different levels of WNT signaling. This 
study expands the traditional binary view of canonical WNT signaling and helps illuminate 
WNT/β-catenin activity in other developmental and disease contexts. 
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CHAPTER 4 
THE ROLE OF THE WNT/BCATENIN INDUCED TRANSCRIPTION FACTOR, SP5 IN NEURAL 
PATTERNING	
4.1. Introduction 
Signaling pathways convey complex information resulting in the dissemination of 
information required during development for the generation of a properly formed adult organism. 
The WNT/ β-catenin signaling is one such pathway, conserved across all metazoans which 
transmits such information. It plays roles in a multitude of cell and developmental processes 
including formation of the primitive streak, gastrulation, and patterning of anterior/posterior and 
dorsal/ventral axes(Loh, van Amerongen, et al., 2016). Mutations in this pathway compromising 
parts of the pathway can lead to severe congenital defects. While mutations resulting in aberrant 
activation of different components in this pathway can result in the developmental of multiple 
forms of cancer (Clevers & Nusse, 2012; Wiese, Nusse, & van Amerongen, 2018).  
Activation of the WNT/ β-catenin signaling pathway results in accumulation of β-catenin in 
the cytoplasm of cells, which subsequently translocates to the nucleus, where it interacts with 
TCF/LEF transcription factors to activate WNT target genes. The activation of WNT target genes 
by β-catenin is well known to play critical developmental roles, for example in mesoendoermal 
differentiation (Estarás et al., 2015). Although many studies have focused on characterizing 
transcriptional activation by β-catenin, less work has focused on how these signals are turned off 
in an appropriate temporal fashion.  
The SP1 like transcription factor, SP5, is activated following WNT stimulation and acts as a 
selective transcriptional repressor (Dunty, Kennedy, Chalamalasetty, Campbell, & Yamaguchi, 
2014b; Fujimura et al., 2007). SP5 is expressed in multiple tissues throughout mouse 
development localized to regions where WNT signaling is active (C. J. Thorpe, Weidinger, & 
Moon, 2005; Weidinger, Thorpe, Wuennenberg-Stapleton, Ngai, & Moon, 2005a). Recent work in 
human pluripotent stem cells demonstrates that SP5 acts as a WNT induced negative regulator of 
WNT signaling, reining in expression of previously activated WNT target genes (Huggins et al., 
2017). Work in mouse embryos posits an alternate hypothesis, that SP5 plays a role as a co-
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activator, fine tuning WNT signaling by interacting with enhancers to help activate WNT target 
genes (Kennedy et al., 2016). These contradictory roles suggest it is possible that SP5 has 
different functions in different mammalian or developmental contexts.  
Here we examine the role of SP5 in early human neural patterning. Previous work has 
demonstrated that a gradient of WNT signaling specifies regional identity in the developing neural 
tube, through β-catenin binding. We demonstrate the SP5 is strongly induced by WNT signaling 
in A/P patterning and is directly regulated by β-catenin binding. Preliminary studies indicate that 
genetic knockout of SP5 results in impaired neural patterning, indicating its essential role in 
neural development is in activating regionally specific genes. This work further demonstrates SP5 
as an essential regulator of canonical WNT signaling; however more in depth characterization is 
required to understand its complete mechanism of action. 
4.2. Experimental Methods 
4.2.1. Cells and culture conditions 
hPSCs were passaged in feeder free conditions in Essential 8 medium (Life Technologies) 
on Matrigel (BD Biosciences). Cells were routinely passaged with Accutase (Millipore) and 
replated at a density of 4.25 x 104/cm2 every 3-4 days. 
4.2.2. Neural progenitor cell (NPC) generation, expansion, and differentiation 
Neural differentiation and patterning were carried out as described previously (Cutts et al., 
2016). Briefly, to initiate neural differentiation, hPSCs were cultured on Matrigel (BD Biosciences) 
in Essential 8 (Life Technologies). Cells were then detached with treatment with Accutase 
(Millipore) for 5 min and resuspended in E8 and replated at 2 x 106 cells per well of a 6 well ultra 
low attachment plate (Grenier). The plates were then placed on an orbital shaker set at 95 rpm in 
a 37°C/5% CO2 tissue culture incubator A fresh half media change was performed after 24, and 
media was exchanged to neural induction media (1% N2/1% B27 without vitamin A/DMEM:F12) 
supplemented with 5 µM Y-267632 (Stemgent), 50 ng/ml recombinant mouse Noggin (R&D 
Systems), 0.5 µM Dorsomorphin (Tocris Bioscience)] after 48 hours. Half media changes were 
subsequently performed every day. After 2 days in suspension in neural induction media, the EBs 
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were patterned by the addition of IWP2 (Sigma) or CHIR98014 (Sigma). Cultures were 
maintained for an additional 5 days before further characterization or analysis. 
4.2.3. Quantitative PCR (qPCR) 
RNA was isolated from cells using Nucelospin RNA®  (Macherey-Nagel. Reverse 
transcription was performed with iScript™ cDNA Supermix (BioRad). Quantitative PCR was 
carried out using SYBR probes (IDT) a CFX384 Touch™ (BioRad) and iTaq Universal SYBR 
Green Supermix (BioRad), with a 2 min gradient to 95°C followed by 40 cycles at 95°C for 5s and 
60°C for 30s. Gene expression was normalized to 18S rRNA levels. Delta Ct values were 
calculated as Ct target– Ct18s. All experiments were performed with two technical replicates. 
Relative fold changes in gene expression were calculated using the 2-ΔΔCt method. Data are 
presented as the average of the biological replicates ± standard error of the mean (S.E.M). 
4.2.4. Chromatin Immunoprecipitation (ChIP) 
Chromatin immunoprecipitation was performed as in Estaras et. al with some modifications. 
(Estarás, Benner, & Jones, 2015). 2 x 107 cells were double crosslinked with 0.2 mM di (N-
succinimidyl) glutarate (DSG, Sigma, 80424) for 45 min followed by 1% formaldehyde 
(ThermFisher Scientific, 28906) for 15 min. Cell were lysed with cell lysis buffer (10 mM Tris pH 
8.0, 10 mM NaCL, 0.2% NP40, protease inhibitors) for ice on 10 min, spun down at 2500 RPM 
and lysed in nuclei lysis buffer (50 mM Tris 8.1, 2 mM EDTA, 1% SDS, protease inhibitors) for 10 
min on ice. Lysate was sonicated in IP dilution buffer (20 mM Tris pH 8.1, 2 mM EDTA, 150 mM 
NaCal, 1% Triton X-100, 0.1% SDS, protease inhibitors) in a Qsonica Q700 bath sonicator at 
amplitude 60, 15 seconds ON, 45 seconds OFF for a process time of 3:45, repeated 8 times. 
Subsequently sonicated lysates were spun down at max RPM for 10 min  precleared with 
magnetic beads (ThermoFisher, 88802) for 1 hour, and subjected to 5 ug α-GFP (Abcam, ab290) 
overnight. Following overnight incubation with anitbody, a one hour incubation with A/G magnetic 
beads was performed followed by subsequent washes with low salt wash buffer (0.1% SDS, 1% 
Triton X-100, 2 mM EDTA, 20 mM Tris-Hcl pH 8.0, 150 mM NaCl), high salt wash buffer (0.1% 
SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris, pH 8.0, 500 mM NaCl), LiCl wash buffer (0.25M 
LiCL, 1% NP40, 1% deoxycholate, 1 mM EDTA, 20 mM Tris pH 8.0), and 2x TE washes. DNA 
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was then eluted in fresh elution buffer and uncrosslinked at 65 C for 4 hours with NaCL treatment 
and treated overnight at 50 C with proteinase K.  
4.3. Results and Discussion 
4.3.1. SP5 is strongly induced in neural patterning 
Using our previously developed in vitro model of A/P neural patterning, and assaying for 
SP5 gene expression indicates that SP5 is strongly induced in response to WNT stimulation and 
most highly expressed in midbrain and posterior patterned neural cells (Figure 4.1A). These 
findings corroborate studies that demonstrate strong induction of SP5 upon WNT stimulation 
(Dunty, Kennedy, Chalamalasetty, Campbell, & Yamaguchi, 2014a; C. J. Thorpe et al., 2005). β-
catenin ChIP-seq in patterned hNPCs demonstrates that SP5 a strongly bound target of 
canonical WNT signaling in midbrain and posterior patterned hNPC fates (Figure 4.1B). This 
provides direct transcriptional evidence of WNT/β-catenin regulated expression of SP5. 
Furthermore, an AAV- based targeting strategy was used by Huggins et. al. to generate a SP5-
YFP fusion protein (Huggins et al., 2017). We used this engineered line to assay SP5 levels with 
flow cytometry, which confirms gene expression results demonstrating strong induction of SP5 in 
midbrain and posterior patterned hNPCs (Figure 4.1C). 
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Figure 4.1 Characterization of the Role of the Negative Regulator of WNT Signaling SP5 in 
Human Neural Patterning A) Expression of WNT targets AXIN2 and SP5 in H1 WT hPSCs 
differentiated to A-, M-, and P- identities (mean ± SEM, n = 3 independent experiments) B) IGV 
trace of SP5 locus in β-catenin ChIP-seq performed in A-, M-, and P- patterned hNPCs C) Flow 
cytometry of A/P patterned hNPCs generated from SP5-YFP fusion hPSCs 
To investigate the role of SP5 in neural patterning we used a line generated by Huggins et 
al. which used CRISPR/Cas9 to engineer cells carrying a loss of function SP5 by truncating the 
zinc finger (ZF) binding domain in the SP5 gene (Figure 4.2A) (Huggins et al., 2017). Repair by 
non-homologous end joining yielded a SP5 allele that expressed a truncated SP5 protein lacking 
the ZF binding domain, designated SP5 DZF, functionally equivalent to a knockout of this protein. 
Sequencing of PCR products of the genomic region containing the targeted region confirmed that 
several clones contained deletions in both alleles of the Zn finger-encoding region (data not 
shown). To investigate the degree to which SP5 acts downstream of WNT signaling to specify 
posterior identities of hPSC-derived cell, we differentiated the SP5 DZF hESC line to neural cells 
of various A/P neural cell identities and performed qPCR for known targets of A/P patterning. In 
midbrain patterned hNPCs SP5 dzf impairs expression of known midbrain markers EN1 and 
LMX1B (Figure 4.2 B). Similarly in posterior patterned hNPCs induction of markers of hindbrain 
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and spinal cord HOXA2 and HOXC4 are impaired in SP5 DZF hESCs (Figure 4.2 B).  
Comparison of gene expression using qPCR thus revealed impairment of M- and P- hNPC cell 
identity in SP5 dzf cell line in patterned NPCs, suggesting that SP5 plays a role inactivating 
expression of these genes in neural patterning. 
. 
	
Figure 4.2 SP5 DZF impairs Neural Patterning A) CRISPR based targeting strategy to generate 
truncated SP5 DZF hESC line B) Expression of cortical-, forebrain-, midbrain-, hindbrain-related 
neuronal genes in hNPCs differentiated to A-, M-, and P- cultures derived from H1 WT and H1 
SP5-dZF hPSCs (mean ± SEM, n = 3 independent experiments). Populations were compared 
with H1 WT hPSCs using Student’s t test. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001. 
4.3.2. SP5 ChIP-qPCR in hES and patterned hNPCS 
To assess SP5 binding in neural patterned cells we treated SP5-YFP hESCs for 48 hours 
with CHIR98014 and performed ChIP. Cells were isolated and DNA was precipitated using an α-
GFP ChIP quality antibody. ChIP-qPCR was performed against the promoter of SP5. WNT 
activation with CHIR98014 had higher amounts of SP5 bound to the promoter of SP5 than 
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untreated cells (Figure 4.3A). This is consistent with the notion that SP5 regulates its own 
expression. We proceeded to examine if SP5 binding is conserved in patterned hNPCs. Using 
our established procotol we patterned hNPCs using a gradient of WNT in the SP5-YFP fusion 
hESC line, CHIP followed by qPCR for the promoter of SP5 indicates that SP5 pulldown in the 
promoter of SP5 in midbrain and posterior patterned hNPCs is higher than anterior patterned 
hNPCs (Figure 4.3B). The SP5-YFP fusion line and protocols developed can thus be used in 
future ChIP-seq studies to enable complete understanding of the mechanistic role of SP5 in 
human A/P patterning.  
	
Figure 4.3 Genomic binding analysis of SP5 in human neural patterning A) anti-GFP ChIP-qPCR 
on the promoter of SP5 in SP5-YFP fusion hPSCs treated with or without 1 uM CHIR for 48 hours 
(mean ± SEM, n = 3 independent experiments) B) anti-GFP ChIP-qPCR on the promoter of SP5 
in A/P patterned hNPCs generated from SP5-YFP fusion hPSCs (mean ± SEM, n = 3 
independent experiments) 
4.4. Conclusion 
5.  
WNT/ β-catenin signaling is required for proper development and maintenance of many 
adult organs; here we examine the role of the WNT induced transcription factor SP5 in the events 
of early human neural patterning. WNT/ β-catenin activation has been demonstrated to be 
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essential to the patterning of the early human neural tube (D. Brafman & Willert, 2017; Mulligan & 
Cheyette, 2012). It has been demonstrated to essential for the proper induction of midbrain, as 
illustrated by the complete loss of metencephalic regions following loss of WNT1 expression (A P 
McMahon et al., 1992). Additionally WNT3a secreted from the paraxial mesoderm stimulates 
expression of Meis3, which in turn is essential for proper formation of the hindbrain (Elkouby et 
al., 2010). WNT/ β-catenin is thus critical for the proper activation of transcriptional programs 
related to neural patterning. How these gene programs are appropriately turned off subsequent to 
WNT stimulated activation remained an open question. 
Several mechanisms of negative feedback in WNT/ β-catenin signaling have been 
identified that target WNT ligands (SFRPs, DKK, NOTUM), FZD receptors (RNF43, APCDD1), 
and parts of the intracellular signaling cascade (AXIN2) (Huggins et al., 2017; Lustig et al., 2002). 
However these mechanisms do not address the deactivation of target genes already turned on by 
WNT signaling. SP5 is a WNT induced transcriptional negative regulator of WNT target genes in 
early human development (Huggins et al., 2017; Weidinger, Thorpe, Wuennenberg-Stapleton, 
Ngai, & Moon, 2005b). Interestingly SP5’s function in WNT signaling is debated in different 
contexts, in mouse embryos it acts as a dual activator with β-catenin to fine tune activation of 
WNT target genes, while in hPSC mediated differentiation it acts as a WNT induced negative 
regulator of WNT target genes to rein in expression of these genes (Huggins et al., 2017; 
Kennedy et al., 2016). 
The role of SP5 in neural patterning has been partially characterized in Xenopus and 
murine studies, where knockout of the protein exhibits patterning defects and tail truncations 
(Dunty et al., 2014a; C. J. Thorpe et al., 2005; Weidinger et al., 2005b). These studies suggest 
that in neural development, SP5 acts as an activator essential to the formation of the 
tailbud/posterior neural tube. Here we build on these previous studies to demonstrate the 
transcriptional role of SP5 in early human neural patterning using our in vitro model of neural 
development. We show that SP5 is strongly induced in our in vitro model of neural differentiation 
and patterning, under the direct control of β-catenin binding. Additionally using a previously 
generated SP5 mutant hPSC line missing the ZF binding domain of SP5 we demonstrate that 
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neural patterning is impaired midbrain and posterior patterned hNPCs, These results suggest that 
in human neural patterning SP5 acts as an activator of midbrain and posterior transcriptional 
programs, potentially in conjunction with β-catenin as has been previously observed in 
gastrulation events in mouse studies (Kennedy et al., 2016). Finally we show that SP5 binds to its 
own promoter in the context of neural development, similar previously identified ability to regulate 
its own expression in hPSCs (Huggins et al., 2017). Future ChIP-seq studies will enable global 
characterization of SP5 binding during neural patterning in anterior, midbrain, and posterior 
patterned hNPCs providing mechanistic insight into its transcriptional activity. 
These observed results appear to be contradictory to SP5’s previously demonstrated action 
as a negative regulator of WNT target genes (Huggins et al., 2017). However it could be possible 
that SP5 has evolved to have context specific mechanisms of action, to act as a negative 
regulator of WNT targets in early pluripotent stem cell differentiation to act as an activator to fine 
tune WNT target gene activation in the context of neural patterning.  
Future work will use ChIP-seq to examine the binding patterns of SP5 during neural 
patterning, we would hypothesize that SP5 acts similarly to previous observations, with β-catenin 
at enhancers to fine-tune the activation of WNT target genes required for normal neural 
patterning. If this is true, the mechanism that deactivates the midbrain specific transcriptional 
program remains elusive. Potential mechanisms involving miRNA-mediated deactivation are 
being examined to account for the precise control over this process. Unraveling the concentration 
dependent negative regulation activity of WNT signaling in this developmental context will 
enhance our understanding of this pathway, opening up novel therapeutic avenues to treat the 
myriad of diseases affected by dysregulated aspects of this signaling pathway. 
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CHAPTER 5 
  SUMMARY AND FUTURE PERSPECTIVE 
5.1. Summary and Future Perspectives 
5.1.1. Specific Aim 1: Development and characterization of an in vitro model of 
neural patterning using human pluripotent stem cells 
In this first aim we developed and characterized an in vitro model of neural patterning using 
human pluripotent stem cells (hPSCs). We generated a WNT responsive reporter line and 
identified heterogeneity in endogenous WNT signaling in hNPCs as the source of regional identity 
during the differentiation from hPSCs. These regional identities are stable over long term 
passaging as apposed to the pluripotent metastable state of hPSCs they were derived from 
(Cahan & Daley, 2013). These findings corroborate earlier findings from developmental biology 
studies that demonstrate a gradient of WNT signaling controls the early positional identity of 
neural progenitors in the neural tube (Kiecker & Niehrs, 2001; Nordström et al., 2002). Other 
studies have generated regional fates using manipulation of RAs or FGFs (Dimos et al., 2008; D. 
Yang et al., 2008). We demonstrate that WNT signaling initially specifies regional identity 
suggesting that additional signals such as RA or FGFs may play roles in further refinement of cell 
identity. Additionally we demonstrate that exogenous manipulation of WNT signaling during 
differentiation of hNPCs leads to pure populations of positionally specified neural progenitor cells. 
These findings can be used to generate neural progenitor cells and neurons with specific regional 
identities to perform disease modeling or cellular therapies for neurodegerative diseases or injury, 
which affect specific regions of the adult brain. In summary we develop and characterize a 
system of human neural patterning using human pluripotent stem cells that demonstrates WNT 
signaling as controlling the A/P axis of the developing neural tube. 
5.1.2. Specific Aim 2: Characterization of the role of β-catenin in regulating fate 
decisions of human neural progenitor cells in neural patterning 
The second aim further utilizes our previously generated model of human neural patterning 
in human pluripotent stem cells. We investigate the transcriptional mechanisms that control the 
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generation of positional identity in the developing neural tube. As described previously specific 
thresholds of β-catenin elicit distinct transcriptional signatures. Graded amounts of WNT signaling 
elicit unique transcriptional signatures due to β-catenin binding. Furthermore we generated a 3X 
flag β-catenin hPSC line to characterize β-catenin binding genome wide using ChIP-seq. We 
found that β-catenin binds mainly unique elements different levels of WNT signaling. We 
additionally characterized the epigenetic landscape of human neural patterning by 
computationally identifying enhancer elements using a machine learning based algorithm 
(Rajagopal et al., 2013). Using this information we found that a majority of β-catenin binding is in 
enhancer elements. These findings prompt a revision of the model of WNT elicited transcription in 
which β-catenin binds different context specific enhancer elements at varying concentrations of 
WNT signaling to specify regional fate of neural progenitor cells. These findings have broader 
impacts on how we view canonical WNT signaling in the context of cancer development and the 
generation of efficacious therapeutics to treat diseases caused by aberrant WNT signaling 
5.1.3. Specific Aim 3: Characterization of the role of negative regulators of WNT 
signaling in regulating fate decisions of human neural progenitor cells in 
neural patterning 
The third aim investigated potential mechanisms of negative regulation of WNT signaling in 
the context of neural development. WNT activation leads to specification of regional identity via 
activation of specific transcriptional signatures mediated through β-catenin binding. Although we 
previously demonstrated that β-catenin regulates acquisition of positional cell identity in the 
developing neural tube, how gene signatures are appropriately turned off at differing thresholds of 
WNT signaling remained an open question. To investigate how this occurs we decided to 
examine the role of a WNT induced transcription factor, SP5. The role of SP5 is somewhat 
controversial with some labs demonstrating an activating effect in concert with β-catenin and 
other demonstrating it acting as a negative regulator that binds previously activated WNT target 
genes (Huggins et al., 2017; Kennedy et al., 2016), Developmental biology studies demonstrate a 
role for SP5 in specifying the posterior development of Xenopus embryos with its loss resulting in 
a severe tail truncation phenotype (Chris J Thorpe, Weidinger, & Moon, 2005). Our work shows 
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that SP5 is highly expressed in midbrain and posterior patterned hNPCs. Subsequent knockdown 
of SP5 during neural patterning results in impairment of patterning to midbrain and posterior 
fates, indicating that it plays a role in activating these fates, potentially in concert with β-catenin. 
Furthermore I performed initial SP5 ChIP experiments that demonstrate SP5 binds its own 
promoter, consistent with previous work (Huggins et al., 2017), to regulate its own expression in 
neural patterning. Further work will be necessary to interrogate the role of SP5 in neural 
patterning. 
5.2. Significance and Contributions 
The outcomes of our work have been presented as peer-reviewed journal articles and 
oral/poster presentations in national and international conferences. Summary of our contributions 
are listed in below. 
1. Moya, N., Cutts, J., Gaasterland, T., Willert, K., & Brafman, D. A. (2014). Endogenous WNT 
Signaling Regulates hPSC-Derived Neural Progenitor Cell Heterogeneity and Specifies 
Their Regional Identity. Stem Cell Reports, 3(6), 1015–1028. 
2. Cutts J, Nikkhah M, Brafman DA. (2015) Biomaterial Approaches for Stem Cell-Based 
Myocardial Tissue Engineering. Biomark. Insights 10(Suppl 1):77-90. 
3. Cutts J, Brookhouser N, Brafman DA. (2016) Generation of Regionally Specific Neural 
Progenitor Cells (NPCs) and Neurons from Human Pluripotent Stem Cells (hPSCs). In: Vol 
; 2016:121-144. 
4. Cutts J, Brafman DA. Transcriptional regulation of regional neural fate through WNT/B-catenin 
signaling. In preparation. 
Talk/poster conferences: 
Engineering Multicellular Self Organization 2017 
Investigating the Mechanism of a Multi-State Model of WNT Signaling 
 
Biomedical Engineering Society 2017 
Investigating the Mechanism of a Multi-State Model of WNT Signaling 
 
International Society for Stem Cell Research (ISSCR) 2017 
Investigating the Mechanism of a Multi-State Model of WNT Signaling 
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Molecular, Cellular, and Tissue Bioengineering Symposium 2017 
Investigating the Mechanism of a Multi-State Model of WNT Signaling 
 
International Society for Stem Cell Research 2016 
Investigating the Mechanism of a Multi-State Model of WNT Signaling 
 
Arizona Alzheimer’s Consortium 2016 
WNT Signaling Specifies Regional Identity of hPSC-derived Neurons 
 
5.3. Significance and Contributions 
Few	studies	have	taken	into	consideration	the	graded	effects	of	WNT	signaling	and	of	
these	none	have	investigated	the	transcriptional	mechanism	that	allows	different	transcriptional	
outputs	at	different	levels	of	WNT	signaling.	(Kirkeby,	Grealish,	et	al.,	2012a;	Tiago	C.	Luis	et	al.,	
2011)	Here	we	characterize	β-catenin	binding	in	a	graded	fashion	using	a	model	of	in	vitro	
neural	development	we	developed.	We	demonstrate	that	specific	levels	of	WNT	activation	lead	
to	different	cell	fates.	We	find	that	in	line	with	previous	observations,	most	β-catenin	binding	
lies	within	enhancers	to	influence	cell	fate,	likely	through	an	enhancer	promoter	looping	
mechanism	(Estarás	et	al.,	2015b;	Yochum,	2011;	Yochum	et	al.,	2010).	Additionally	we	observe	
β-catenin	binding	falls	into	different	classes	depending	on	the	presence	or	absence	of	peaks	at	
different	levels	of	WNT	signaling.	Few	peaks	overlap	between	graded	levels	of	WNT	activation	
while	most	are	unique	to	different	levels	of	WNT	signaling,	corresponding	to	different	hNPC	
fates.	This	study	expands	the	traditional	binary	view	of	canonical	WNT	signaling	and	could	help	
illuminate	WNT/β-catenin	activity	in	other	developmental	and	diseased	contexts.	 
Our work focuses mainly on the activating role of WNT signaling in specifying regional 
identity, how gene programs are appropriately turned off subsequent to WNT stimulated 
activation remains an open question. There are multiple possibilities regarding how this process 
could be regulated. One promising mechanism currently under investigation in the lab is the role 
of mirco rna (miRNA) in relation to canonical WNT signaling which may play a role in turning off 
M- signature genes. MicroRNAs are small non-coding RNAs that interact with a RNA-induced 
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silencing complex (RISC) to silence expression of mRNA (Macfarlane & Murphy, 2010). 
Preliminary findings from this work indicate that mir10a is upregulated in posterior patterned 
hNPCs. This suggests that this miRNA may play a role as a WNT induced negative regulator of 
WNT signaling. Of course additional transcription factors from alternative signaling pathways 
could act to impart the proper transcriptional signature. SP5 is a WNT induced negative regulator 
of WNT signaling that our preliminary work indicates plays an important role in neural patterning 
(Huggins et al., 2017). Although our initial work suggests it could play a role in activation further 
studies that utilize ChIP-seq and overexpression of SP5 in our model of neural development will 
help interrogate its complete mechanism of action. Additionally, FGFs and RAs are known to play 
a role in activation of mid- and hindbrain fates and could be responsible for repressing alternative 
neural progenitor fates, potentially through a WNT mediated mechanism. It’s likely that a 
combination of several of these mechanisms work together to ensure proper patterning on the 
developing neural tube. 
 The discovery that cells can self organize has ushered in a new era of developmental 
biology with the use of cell organoids . Further understanding of the WNT regulated molecular 
mechanisms involved in neural patterning will enable more accurate engineering of novel neural 
organoids furthering our ability to model diseases, screen therapeutics, and treat 
neurodegenerative diseases. This will necessitate novel bioengineering techniques that employ 
the use of mitogen gradients to properly specify regional fate of neural progenitors in an 
appropriate spatiotemporal fashion. WNT signaling is fundamentally known to help establish body 
axis in developing organisms (Loh, van Amerongen, et al., 2016), future bioengineering efforts 
should take these signals into account. 
WNT plays known roles in the genesis of many forms cancer, much work continues to be 
done to find treatments for WNT caused cancers (B. Chen et al., 2009; Wiese et al., 2018). 
However our understanding of how WNT elicits transcription continues to evolve. Here we 
expand the traditional view of WNT elicited transcription using a graded model of WNT signaling. 
Different thresholds elicit different transcriptional signatures in development of the neural tube. 
This prompts a reinvestigation of the level of WNT signaling in different types of cancers and 
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potentially even among different patients with the same cancer. A hypothesis known as the ‘just 
right hypothesis’ posits that a low level of WNT signaling leads to cancerous phenotype while 
higher levels lead to apoptosis (Albuquerque et al., 2002). The development of different types of 
cancers involve the dysregulation of multiple signaling pathways, WNT dysregulation plays a 
prominent role in the genesis of many types of cnancers. However our results suggest that 
different levels of WNT could need entirely different treatments because different levels of WNT 
elicit unique transcriptional signatures. Thus the current state of WNT investigation into cancer 
should avoid the traditional two state model of WNT signaling in the treatment of cancers affected 
by WNT signaling. It will be important to take this into consideration, not only for WNT signaling 
as it is likely this graded mechanisms exit to regulate many different signaling pathways.  
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Figure A.1 Generation of clonal WNT reporter hESC lines. A) Schematic of TOP-GFP lentiviral 
construct. B) Flow cytometry analysis of expanded clones after 48 hour treatment with 15 nM 
purified mouse WNT3a. Clone 19 (hTOP-19) displayed the highest expression of GFP after 
WNT3a treatment. C) Karyotype analysis of hTOP-19. Chromosome spread indicated a normal 
euploid female karyotype (46XX). D) Flow cytometry analysis of hTOP-19 hESCs treated with 
various concentrations of WNT3a. E) Flow cytometry analysis of hTOP-19 hESCs treated with 
GSK3β inhibitor BIO. F) Flow cytometry analysis of GFP expression in reporter expressing NPCs 
after 48 hours of treatment with 15 nM WNT3a or 1000 nM IWP2. Abbreviations: NFC=Non-
fluorescing channel. 
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Figure A.2  Differentiation of hPSCs to neural progenitor cells (NPCs) and neurons A) Overview 
of differentiation protocol for differentiation of hPSCs to NPCs and neruons. The soluble factors, 
substrate, and culture media at each stage are shown. B) Immunofluorescence of OCT4, 
NANOG, SOX2, and SOX1 in hESCs and NPCs (scale bar = 100 µm), C) Flow cytometry 
analysis of SOX1 and SOX2 expression in HESCs and NPCs. Isotype controls used are listed in 
Table S2 D) Phase contrast images of hESCs and NPCs (scale bar = 100 µm). E) Gene 
expression analysis of anterior/posterior (A/P) neural tube related genes in hESCs and NPCs 
(mean ± S.E.M., n=3 independent experiments). Populations were compared using Student’s t-
test. *p<0.05, **p<0.01, ***p<0.001. Flow cytometry analysis of F) FORSE-1 and G) PAX6 in 
NPCs H) Immunofluorescence of HOXB4 in NPCs (scale bar = 200 µm). I) Immunofluorescence 
of B3T in neuronal cultures (scale bar = 1 mm). J) Immunofluorescence of MAP2 and GFAP in 
neuronal cultures (scale bar = 200 µm). K) B3T and γ-Aminobutyric acid (GABA) in neurons 
differentiated from hESCs (scale bar = 200 µm). Abbreviations: NFC=Non-fluorescing channel. 
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Figure A.3 Analysis of TOP-GFP expressing NPC populations A) Gene expression analysis of 
SOX2 and NESTIN (mean ± S.E.M., n=3 independent experiments). B) Immunofluorescence of 
NESTIN, SOX1, and SOX2 C) Reporter expressing NPCs were separated by fluorescence-based 
cell sorting into GFPHIGH and GFPLOW populations on the basis of GFP expression. GFPHIGH and 
GFPLOW populations were subsequently cultures for 10 passages (>50 days) and examined for 
expression of WNT and A/P related genes. D) Gene expression of WNT target gene AXIN2 in 
GFP sorted NPC populations after 5 and 10 passages(mean ± S.E.M., n=3 independent 
experiments). E) Gene expression analysis of A/P related genes in GFP sorted NPC populations 
after 5 and 10 passages (mean ± S.E.M., n=3 independent experiments). Populations were 
compared using Student’s t-test. *p<0.05, **p<0.01, ***p<0.001. Abbreviations N.S. = Not 
statistically significant 
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Figure A.4 Analysis of neurons generated from TOP-GFP expressing NPC populations A) Phase 
contrast images of neurons derived from sorted GFP expressing NPC populations (scale bar = 
500 µm). B) Immunofluorescence of mature neuronal markers MAP2 and B3T in neuronal 
cultures differentiated from sorted GFPLOW, GFPMID, and GFPHIGH NPC populations (scale bar = 
200 µm). C) Gene expression analysis of MAP2 and B3T in neuronal cultures differentiated from 
sorted GFPLOW, GFPMID, and GFPHIGH NPC populations (mean ± S.E.M., n=3 independent 
experiments). Populations were compared using Student’s t-test. *p<0.05, **p<0.01, ***p<0.001. 
Abbreviations N.S. = Not statistically significant 
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Figure A.5 Analysis of CHIR-, WNT-, IWP2-, and un-treated embryoid bodies, NPCs, and 
neurons. A) Phase contrast images and size distribution of embryoid bodies (EBs) generated in 
500 nM CHIR-, 1000 nM IWP2, and un-treated conditions (scale bar = 200 µm). B) Size 
distribution of EBs generated in 500 nM CHIR-, 1000 nM IWP2-, and un-treated conditions. The 
diameter of 200 EBs was measured for each condition. C) Gene expression (mean ± S.E.M., n=3 
independent experiments), D) Immunofluorescence (scale bar = 100 µm), and E) flow cytometry 
analysis of NESTIN, SOX1, and SOX2 of NPCs generated in 500 nM CHIR-, 1000 nM IWP2-, 
and un-treated conditions. Isotype controls used are listed in Table S2 F) Gene expression 
analysis of anterior/posterior (A/P) neural tube related genes in NPCs (mean ± S.E.M., n=3 
independent experiments) generated in the presence of various WNT concentrations. Populations 
were compared using Student’s t-test. *p<0.05, **p<0.01, ***p<0.001. G) Gene expression 
analysis of MAP2 and B3T in neuronal cultures differentiated from NPCs generated in 500 nM 
CHIR-, 1000 nM IWP2-, and un-treated conditions (mean ± S.E.M., n=4 independent 
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Figure A.6 Analysis of stability of patterning of NPCs imposed by exogenous WNT manipulation 
A) Posterior-patterned NPCs (i.e. NPCs generated in the presence of 500 nM CHIR) were 
cultures without CHIR (C-N) or in the presence of 500 nM CHIR (C-C) or 1000 nM IWP2 (C-I) for 
10 passages. B) Anterior-patterned NPCs (i.e. NPCs generated in the presence of 1000 nM IWP2 
were cultures without IWP2 (I-N) or in the presence of 500 nM CHIR (I-C) or 1000 nM IWP2 (I-I) 
for 10 passages. Expression of C) FOXG1 and D) HOXB4 was assessed in all conditions after 10 
passages and compared to initial passage (P0) NPC cultures (mean ± S.E.M., n=3 independent 
experiments) . Populations were compared using Student’s t-test. *p<0.05, **p<0.01, ***p<0.001. 
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Table A. 1 TaqMan gene expression assays used in this study. 
	
 
	
	
	
Gene	 ABI	Assay	
18s	 Hs99999901_s1	
AXIN2	 Hs00610344_m1	
CTIP2	(BCL11B)	 Hs00256257_m1	
CHAT	 Hs00252848_m1	
CUX1	 Hs00738851_m1	
DLX2	 Hs00269993_m1	
EMX1	 Hs00417957_m1	
EN1	 Hs00154977_m1	
FGF5	 Hs03676587_s1	
FOXG1	 Hs01850784_s1	
GABRA1	 Hs00168058_m1	
GATA2	 Hs00231119_m1	
GATA3	 Hs00231122_m1	
GFAP	 Hs00157674_m1	
HOXB4	 Hs00256884-m1	
HOXB6	 Hs00980016_m1		
IRX3	 Hs00735523_m1	
LMX1A	 Hs00892663_m1	
LMX1B	 Hs00158750_m1	
MAP2	 Hs00258900_m1	
MNX1	(HB9)	 Hs00907365_m1	
NES	 Hs00707120_s1	
NURR1	(NR4A2)	 Hs00428691_m1	
OTX2	 Hs00222238-m1	
PITX3	 Hs01013935_g1	
SATB2	 Hs00392652_m1	
SIX3	 Hs00193667_m1	
SOX1	 HS01057642_s1	
SOX2	 Hs01053049_s1	
SP5	 Hs01370227_mH	
TH	 Hs00165941_m1	
TUBB3	 Hs00801390_s1	
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Table A 2 Antibodies used in this study 
	
 
	
 
 
 
 
	
	
Antibody	 Vendor	 Catalog	#	 Concentration	Used	
Goat	anti-SOX2	 Santa	Cruz	 SC-17320	 1:50	
Goat	anti-OTX2	 R&D	Systems	 AF1979	 1:200	
Mouse	anti-B3T	 Fitzgerald	 10R-T136A	 1:1000	
Mouse	anti-EN1	 DSHB	 4G11	 1:800	
Mouse	anti-FORSE-1	 DSHB	 Concentrate	 1:75	
Mouse	anti-GFAP	 Millipore	 AB360	 1:500	
Mouse	anti-MNX1	 DSHB	 81.5C10	 1:100	
Mouse	anti-Nestin	 BD	 560341	 1:10	
Mouse	anti-SOX1	 BD	 560749	 1:10	
Rabbit	anti-FOXG1	 Abcam	 AB18259	 1:100	
Rabbit	anti-GABA	 Millipore	 AB15415	 1:200	
Rabbit	anti-HOXA2	 Sigma	 HPA029774	 1:200	
Rabbit	anti-HOXB4	 Abcam	 AB76093	 1:10	
Rabbit	anti-LMX1A	 Abcam	 AB139726	 1:100	
Rabbit	anti-MAP2	 Millipore	 AB5622	 1:500	
Rabbit	anti-NANOG	 Santa	Cruz	 SC-33759	 1:50	
Rabbit	anti-NURR1	 Millipore	 AB5778	 1:200	
Rabbit	anti-OCT4	 Santa	Cruz	 SC-9081	 1:50	
Rabbit	anti-TBR1	 Abcam	 AB31940	 1:200	
Alexa-647	Mouse	Anti-SOX2	 BD	 560294	 20	µl	per	test	
PE	Mouse	anti-Nestin	 BD	 561230	 5	µl	per	test	
PE	Mouse	anti-PAX6	 BD	 561552	 5	µl	per	test	
PerCp-Cy5.5	Mouse	anti-SOX1	 BD	 561549	 5	µl	per	test	
Alexa-647	Mouse	IgG2a	Isotype	Control	 BD	 558053	 20	µl	per	test	
PE	Mouse	IgG1	Isotype	Control	 BioLegend	 400113	 5	ul	per	test	
PE	Mouse	IgG2a	Isotype	Control	 BD	 561552	 5	ul	per	test	
PercCp-Cy5.5	MouseIgG1	Isotype	Control	 BD	 550795	 5	ul	per	test	
Alexa	647	Donkey	Anti-Goat	 Life	Technologies	 A-21447	 1:200	
Alexa	647	Donkey	Anti-Rabbit	 Life	Technologies	 A-31573	 1:200	
Alexa	647	Donkey	Anti-Mouse	 Life	Technologies	 A-31571	 1:200	
Alexa	546	Donkey	Anti-Goat	 Life	Technologies	 A-11056	 1:200	
Alexa	546	Donkey	Anti-Rabbit	 Life	Technologies	 A-10040	 1:200	
Alexa	546	Donkey	Anti-Mouse	 Life	Technologies	 A-10036	 1:200	
Alexa	488	Donkey	Anti-Goat	 Life	Technologies	 A-11055	 1:200	
Alexa	488	Donkey	Anti-Rabbit	 Life	Technologies	 A-21206	 1:200	
Alexa	488	Donkey	Anti-Mouse	 Life	Technologies	 A-21202	 1:200	
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APPENDIX B 
SUPPLEMENTARY FIGURES FOR CHAPTER 3 
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Figure B.1 Validation of characterization of in vitro model of neural patterning A) Gene-expression 
analysis of A/P related genes in A/P patterned hNPCs (mean ± SEM, n=3 independent 
experiments) B) Genome browser captures of representative genes for H3K9ac, H3K4me3, and 
H3K27ac in respective gene promoters  
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Figure B.2 Generation and characterization of ICAT overexpression embryonic stem cells A) 
Schematic of ICAT overexpression vector B) Gene-expression analysis of ICAT in H1 WT and 
ICAT overexpression (mean ± SEM, n=3 independent experiments) 
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Figure B.3 Generation and characterization of CTNNB1-3XFLAG embryonic stem cells A) 
Schematic of CRISPR mediated strategy to insert 3X FLAG at C-terminus of CTNNB1 B) 
Sequencing of selected CTNNB1-3XFLAG clones C) Fluorescent images of α-FLAG staining of 
CTNNB1-3XFLAG line D) Karyotype analysis of CTNNB1-3X FLAG line E) Phase contrast image 
D) Flow cytometry analysis of pluripotency cell surface marker TRA1-81 G) Fluorescent images 
of pluripotency markers NANOG, OCT4, and SOX2 H) Fluorescent images of CTNNB1-3XFLAG 
cells subjected to undirected differentiation and analyzed for genes representative of germ layers 
SMA, AFP, and B3T. 
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Figure B.4 Analysis of β-catenin identified peaks A) Gene expression analysis of WNT targets 
AXIN2 and B) SP5 in CTNNB1-3XFLAG embryonic stem cells treated with or without 0.5 µm 
CHIR98014 for 48 hours  (mean ± SEM, n=3 independent experiments) C) ChIP-qPCR of SP5 
promoter in CTNNB1-3XFLAG embryonic stem cells treated with or without 0.5 µm CHIR98014 
for 48 hours (mean ± SEM, n=3 independent experiments) D) ChIP-qPCR of SP5 promoter in 
CTNNB1-3XFLAG embryonic stem cells patterned to Anterior (A), Midbrain (M), or Posterior (P) 
patterned hNPCs (mean ± SEM, n=3 independent experiments E) Gene ontology analysis of 
genes regulated by β-catenin peaks identified in Anterior (A), Midbrain (M), and Posterior (P) 
patterned hNPCs. 
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Figure B.5 Analysis of Enhancers identified during neural differentiation and patterning A) Gene 
ontology analysis of genes linked to active enhancers B) Motif analysis of active enhancers 
identified during neural differentiation and patterning 
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